IPOGrid
0000727920
IPO filing research
Equitable Financial Life Insurance Co
Insurance Agents, Brokers & Service
follow-on
effective
EFFECT
Equitable Financial Life Insurance Co IPO research page with SEC filing history, offering status, deal terms, structured filing extracts, company news, and comparable IPO context. Latest filing: EFFECT on 2026-05-01.
Filing Timeline
SEC EDGAR
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B3 and marks the registration effective.
2026-05-01 · 9999999995-26-001433
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B3 and marks the registration effective.
2026-05-01 · 9999999995-26-001422
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
First tracked pre-IPO filing for this issuer.
2026-05-01 · 9999999995-26-001421
S-1/A
amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
First tracked pre-IPO filing for this issuer.
2026-04-21 · 0001193125-26-165890
S-1
filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows EFFECT in the pre-IPO sequence.
2026-02-13 · 0001193125-26-050304
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2025-05-01 · 9999999995-25-001348
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2025-05-01 · 9999999995-25-001347
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows S-1/A and marks the registration effective.
2025-05-01 · 9999999995-25-001346
S-1/A
amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1/A filing.
2025-04-22 · 0001193125-25-089155
S-1/A
amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1/A filing.
2025-04-22 · 0001193125-25-089133
S-1/A
amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior 424B3 filing.
2025-04-22 · 0001193125-25-089122
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows RW and confirms the priced prospectus.
2025-03-11 · 0001193125-25-051503
RW
withdrawn
Withdrawal request
Issuer requested withdrawal of the registration statement.
Follows S-1 and ends the active registration process.
2025-02-28 · 0001193125-25-040944
S-1
filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows S-1 in the pre-IPO sequence.
2025-02-14 · 0001193125-25-027132
S-1
filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows S-1 in the pre-IPO sequence.
index-linked investment option available as a rider under variable flexible premium universal life policies
2025-02-14 · 0001193125-25-027130
S-1
filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows 424B3 in the pre-IPO sequence.
2025-02-14 · 0001193125-25-027120
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2025-02-07 · 0001193125-25-022295
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2024-12-06 · 0001193125-24-272253
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2024-12-06 · 0001193125-24-272249
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2024-12-06 · 0001193125-24-272247
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2024-11-04 · 0001193125-24-250387
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2024-10-04 · 0001193125-24-232688
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2024-09-11 · 0001193125-24-217270
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2024-08-16 · 0001193125-24-201984
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2024-08-14 · 0001193125-24-200293
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2024-08-14 · 0001193125-24-200291
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2024-08-14 · 0001193125-24-200287
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2024-08-01 · 0001193125-24-191017
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2024-07-17 · 0001193125-24-180067
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2024-07-17 · 0001193125-24-180055
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2024-07-17 · 0001193125-24-180049
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
Exchange NASDAQ
2024-06-27 · 0001193125-24-169889
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2024-06-06 · 0001193125-24-155834
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
2024-05-02 · 0001193125-24-128730
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2024-05-01 · 9999999995-24-001295
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2024-05-01 · 9999999995-24-001291
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2024-05-01 · 9999999995-24-001290
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2024-05-01 · 9999999995-24-001289
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B3 and marks the registration effective.
2024-05-01 · 9999999995-24-001287
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
Market Stabilizer Option® tied to S&P 500 Price Return index
2024-04-23 · 0001193125-24-106408
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2024-04-23 · 0001193125-24-106392
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
Exchange NASDAQ · Underwriters Equitable Advisors, LLC, Equitable Distributors, LLC
2024-04-22 · 0001193125-24-104659
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
Exchange NASDAQ
2024-04-22 · 0001193125-24-104644
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2024-04-22 · 0001193125-24-104640
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2024-04-19 · 0001193125-24-102772
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2024-01-11 · 0001193125-24-006361
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2024-01-11 · 0001193125-24-006353
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2024-01-11 · 0001193125-24-006352
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2023-12-21 · 0001193125-23-300715
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
2023-12-21 · 0001193125-23-300672
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B3 and marks the registration effective.
2023-11-13 · 9999999995-23-003314
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2023-11-13 · 0001193125-23-275513
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
2023-11-01 · 0001193125-23-267862
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B3 and marks the registration effective.
2023-10-31 · 9999999995-23-003142
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2023-09-13 · 0001193125-23-234000
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2023-08-25 · 0001193125-23-221082
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2023-07-14 · 0001193125-23-186992
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows RW and confirms the priced prospectus.
2023-07-14 · 0001193125-23-186986
RW
withdrawn
Withdrawal request
Issuer requested withdrawal of the registration statement.
Follows 424B3 and ends the active registration process.
2023-05-26 · 0001193125-23-155017
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
Exchange NASDAQ
2023-05-02 · 0001193125-23-131713
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2023-05-01 · 9999999995-23-001184
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2023-05-01 · 9999999995-23-001183
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2023-05-01 · 9999999995-23-001182
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2023-05-01 · 9999999995-23-001176
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B3 and marks the registration effective.
2023-05-01 · 9999999995-23-001149
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
Variable and index-linked individual and group flexible premium deferred annuity contract · Exchange NASDAQ · Underwriters Equitable Advisors, LLC, Equitable Distributors, LLC
2023-04-21 · 0001193125-23-110122
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
Exchange NASDAQ
2023-04-21 · 0001193125-23-110088
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
Variable and index-linked individual and group flexible premium deferred annuity contract · Exchange NASDAQ · Underwriters Equitable Advisors, LLC, Equitable Distributors, LLC
2023-04-21 · 0001193125-23-110063
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
Variable and index-linked individual and group flexible premium deferred annuity contract · Exchange NASDAQ · Use of proceeds Use of proceeds not specified · Underwriters Equitable Advisors, LLC, Equitable Distributors, LLC
2023-04-21 · 0001193125-23-110042
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
Market Stabilizer Option II (MSO) - index-linked investment rider for variable life insurance policies
2023-04-20 · 0001193125-23-108328
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows RW and confirms the priced prospectus.
2023-04-20 · 0001193125-23-108299
RW
withdrawn
Withdrawal request
Issuer requested withdrawal of the registration statement.
Follows RW and ends the active registration process.
2023-03-31 · 0001193125-23-086875
RW
withdrawn
Withdrawal request
Issuer requested withdrawal of the registration statement.
Follows 424B3 and ends the active registration process.
2023-03-31 · 0001193125-23-086871
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2023-02-08 · 0001193125-23-027969
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2023-02-08 · 0001193125-23-027968
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2023-02-08 · 0001193125-23-027966
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2023-02-08 · 0001193125-23-027964
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2023-02-08 · 0001193125-23-027961
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2023-02-08 · 0001193125-23-027960
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2023-02-08 · 0001193125-23-027957
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2023-01-19 · 0001193125-23-011054
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
Exchange NASDAQ
2023-01-11 · 0001193125-23-006293
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
Exchange NASDAQ
2023-01-11 · 0001193125-23-006284
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
Exchange NASDAQ
2022-12-15 · 0001193125-22-305478
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2022-12-14 · 9999999995-22-003532
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B3 and marks the registration effective.
2022-12-14 · 9999999995-22-003531
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
Exchange NASDAQ
2022-11-14 · 0001193125-22-284631
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B3 and marks the registration effective.
2022-11-10 · 9999999995-22-003262
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
Structured Investment Option (SIO) under variable annuity contract · Exchange NASDAQ
2022-11-10 · 0001193125-22-282101
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2022-11-10 · 0001193125-22-282080
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
Exchange NASDAQ · Underwriters Equitable Advisors, LLC, Equitable Distributors, LLC
2022-11-10 · 0001193125-22-282063
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2022-10-12 · 0001193125-22-261047
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
Exchange NASDAQ
2022-09-30 · 0001193125-22-255109
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2022-06-07 · 0001193125-22-168925
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2022-05-24 · 0001193125-22-158467
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2022-05-24 · 0001193125-22-158459
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
2022-05-18 · 0001193125-22-153747
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2022-05-02 · 9999999995-22-001258
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2022-05-02 · 9999999995-22-001253
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2022-05-02 · 9999999995-22-001251
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2022-05-02 · 9999999995-22-001250
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2022-05-02 · 9999999995-22-001249
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B3 and marks the registration effective.
2022-05-02 · 9999999995-22-001248
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
Variable and index-linked deferred annuity contract · Exchange NASDAQ · Underwriters Equitable Advisors, LLC, Equitable Distributors, LLC
2022-04-26 · 0001193125-22-119041
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2022-04-22 · 0001193125-22-114834
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
2022-04-22 · 0001193125-22-114829
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B3 and marks the registration effective.
2022-04-21 · 9999999995-22-001047
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows RW and confirms the priced prospectus.
2022-04-20 · 0001193125-22-111226
RW
withdrawn
Withdrawal request
Issuer requested withdrawal of the registration statement.
Follows 424B3 and ends the active registration process.
2022-03-09 · 0001193125-22-069891
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2022-02-09 · 0001193125-22-032000
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
Exchange NASDAQ
2022-01-14 · 0001193125-22-009596
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
Exchange NASDAQ
2021-12-29 · 0001193125-21-368879
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
Exchange NASDAQ
2021-12-16 · 0001193125-21-358959
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2021-12-15 · 9999999995-21-004699
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B3 and marks the registration effective.
2021-11-12 · 9999999995-21-004316
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
Variable and index-linked deferred annuity contract · Exchange NASDAQ · Underwriters Equitable Advisors, LLC, Equitable Distributors, LLC
2021-11-12 · 0001193125-21-327735
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows RW and marks the registration effective.
2021-08-18 · 9999999995-21-003241
RW
withdrawn
Withdrawal request
Issuer requested withdrawal of the registration statement.
Follows RW and ends the active registration process.
2021-08-17 · 0001193125-21-248921
RW
withdrawn
Withdrawal request
Issuer requested withdrawal of the registration statement.
Follows 424B3 and ends the active registration process.
2021-08-06 · 0001193125-21-238887
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2021-07-29 · 0001193125-21-228466
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
Market Stabilizer Option
2021-06-14 · 0001193125-21-189750
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
variable and index-linked deferred annuity contract · Exchange NASDAQ · Underwriters Equitable Advisors, LLC, Equitable Distributors, LLC
2021-06-11 · 0001193125-21-188479
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2021-06-10 · 9999999995-21-002293
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2021-05-03 · 9999999995-21-001740
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2021-05-03 · 9999999995-21-001739
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2021-05-03 · 9999999995-21-001738
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B3 and marks the registration effective.
2021-05-03 · 9999999995-21-001732
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
Variable and fixed flexible premium deferred annuity contract
2021-04-22 · 0001193125-21-126907
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
Structured Investment Option under the Investment Edge® 21.0 variable deferred annuity contract · Exchange NASDAQ
2021-04-22 · 0001193125-21-126892
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
Market Stabilizer Option®
2021-04-21 · 0001193125-21-124899
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2021-04-20 · 0001193125-21-122925
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
Exchange NASDAQ
2021-01-25 · 0001193125-21-015734
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2021-01-04 · 0001193125-21-000843
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2021-01-04 · 0001193125-21-000840
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2021-01-04 · 0001193125-21-000837
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
Index-linked investment option available under the Investment Edge 21.0 variable deferred annuity contract · Exchange NASDAQ
2020-12-28 · 0001193125-20-326987
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2020-12-22 · 9999999995-20-003610
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B3 and marks the registration effective.
2020-11-05 · 9999999995-20-003084
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
Exchange NASDAQ
2020-11-04 · 0001193125-20-285308
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows RW and confirms the priced prospectus.
2020-09-29 · 0001193125-20-257468
RW
withdrawn
Withdrawal request
Issuer requested withdrawal of the registration statement.
Follows 424B3 and ends the active registration process.
2020-09-22 · 0001193125-20-250809
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2020-07-02 · 0001193125-20-186562
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2020-07-02 · 0001193125-20-186555
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2020-07-02 · 0001193125-20-186550
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
Use of proceeds Updates to required minimum distribution services due to CARES Act adjustments
2020-06-22 · 0001193125-20-175011
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2020-05-21 · 0001193125-20-148441
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2020-05-21 · 0001193125-20-148438
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2020-05-21 · 0001193125-20-148437
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2020-05-21 · 0001193125-20-148432
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
Underwriters Equitable Distributors, LLC
2020-05-08 · 0001193125-20-137161
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2020-05-07 · 9999999995-20-001075
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2020-05-01 · 9999999995-20-000991
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2020-05-01 · 9999999995-20-000990
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2020-05-01 · 9999999995-20-000989
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2020-05-01 · 9999999995-20-000988
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2020-05-01 · 9999999995-20-000986
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B3 and marks the registration effective.
2020-05-01 · 9999999995-20-000985
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2020-05-01 · 0001193125-20-130220
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2020-05-01 · 0001193125-20-130101
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2020-05-01 · 0001193125-20-130099
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2020-05-01 · 0001193125-20-130097
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2020-05-01 · 0001193125-20-130095
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2020-05-01 · 0001193125-20-129971
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2020-05-01 · 0001193125-20-129931
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2020-02-28 · 0001193125-20-054595
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2020-02-28 · 0001193125-20-054587
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2020-02-28 · 0001193125-20-054577
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2020-02-28 · 0001193125-20-054572
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2020-02-28 · 0001193125-20-054567
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
2020-01-07 · 0001193125-20-002649
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B3 and marks the registration effective.
2019-12-17 · 9999999995-19-002837
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2019-12-17 · 0001193125-19-316197
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2019-11-18 · 0001193125-19-294526
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2019-11-18 · 0001193125-19-294523
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2019-09-26 · 0001193125-19-256129
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2019-08-09 · 0001193125-19-217700
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2019-08-01 · 0001193125-19-210640
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2019-08-01 · 0001193125-19-210638
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2019-08-01 · 0001193125-19-210634
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2019-08-01 · 0001193125-19-210627
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2019-08-01 · 0001193125-19-210625
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2019-08-01 · 0001193125-19-210621
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2019-07-18 · 0001193125-19-196072
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2019-06-13 · 0001193125-19-172339
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2019-06-13 · 0001193125-19-172334
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2019-06-13 · 0001193125-19-172331
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
Use of proceeds No issuer proceeds; exchange of existing contracts for mutual funds without withdrawal charges
2019-05-24 · 0001193125-19-156606
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
Variable annuity contract exchange offer · Selling stockholders only · Use of proceeds No issuer proceeds; exchange of existing contracts for affiliated mutual funds
2019-05-24 · 0001193125-19-156594
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2019-05-01 · 9999999995-19-000969
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2019-05-01 · 9999999995-19-000968
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B3 and marks the registration effective.
2019-05-01 · 9999999995-19-000967
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
individual flexible premium variable life insurance policy issued by AXA Equitable Life Insurance Company with variable investment options offered under AXA Equitable's Separate Account FP
2019-04-19 · 0001193125-19-112276
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2019-04-17 · 0001193125-19-109274
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2019-04-16 · 0001193125-19-107983
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2019-04-08 · 0001193125-19-100365
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2019-04-08 · 0001193125-19-100276
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2019-01-04 · 0001193125-19-002316
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2019-01-04 · 0001193125-19-002311
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2018-12-21 · 0001193125-18-356024
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2018-12-21 · 0001193125-18-356019
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2018-12-06 · 0001193125-18-343113
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2018-11-29 · 0001193125-18-337582
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
Exchange NASDAQ
2018-11-29 · 0001193125-18-337565
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B3 and marks the registration effective.
2018-11-20 · 9999999995-18-002938
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2018-11-15 · 0001193125-18-328083
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2018-11-15 · 0001193125-18-327973
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2018-11-15 · 0001193125-18-327872
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2018-10-19 · 0001193125-18-302690
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2018-10-19 · 0001193125-18-302671
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2018-10-16 · 0001193125-18-300104
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2018-07-30 · 0001193125-18-231280
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
2018-07-30 · 0001193125-18-231168
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2018-05-02 · 9999999995-18-001096
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2018-05-01 · 9999999995-18-001064
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2018-05-01 · 9999999995-18-001063
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2018-05-01 · 9999999995-18-001061
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B3 and marks the registration effective.
2018-05-01 · 9999999995-18-001060
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
Deferred Annuity Contracts
2018-04-18 · 0001193125-18-120906
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
Deferred annuity contract issued by AXA Equitable Life Insurance Company
2018-04-17 · 0001193125-18-119620
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2018-02-14 · 0001193125-18-044408
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2018-02-13 · 0001193125-18-041743
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2018-02-12 · 0001193125-18-039354
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2018-01-25 · 0001193125-18-019323
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2018-01-22 · 0001193125-18-016113
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2018-01-22 · 0001193125-18-016103
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2018-01-22 · 0001193125-18-016093
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
variable and index-linked deferred annuity contract · Underwriters AXA Advisors, LLC, AXA Distributors, LLC
2017-12-28 · 0001193125-17-381388
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
Use of proceeds to fund investment options and retirement savings · Underwriters AXA Advisors, LLC, AXA Distributors, LLC
2017-12-22 · 0001193125-17-377512
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
2017-12-22 · 0001193125-17-377387
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B3 and marks the registration effective.
2017-12-21 · 9999999995-17-003278
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2017-10-20 · 0001193125-17-315152
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2017-08-16 · 0001193125-17-259813
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2017-08-16 · 0001193125-17-259801
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
Structured Capital Strategies(R) PLUS variable and index-linked deferred annuity contract · Underwriters AXA Advisors, LLC, AXA Distributors, LLC
2017-06-20 · 0001193125-17-207982
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
Underwriters AXA Advisors, LLC, AXA Distributors, LLC
2017-06-05 · 0001193125-17-194339
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2017-06-01 · 9999999995-17-001418
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2017-05-01 · 9999999995-17-001129
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2017-04-24 · 9999999995-17-000918
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B3 and marks the registration effective.
2017-04-24 · 9999999995-17-000917
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2017-04-21 · 0001193125-17-132208
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
Exchange NASDAQ
2017-04-19 · 0001193125-17-128982
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2017-04-06 · 0001193125-17-113342
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
Exchange NASDAQ
2017-03-08 · 0001193125-17-074442
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B3 and marks the registration effective.
2017-02-17 · 9999999995-17-000402
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2017-01-20 · 0001193125-17-013346
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
2017-01-10 · 0001193125-17-006952
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B3 and marks the registration effective.
2016-12-30 · 9999999995-17-000012
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
2016-12-27 · 0001193125-16-803524
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B3 and marks the registration effective.
2016-12-23 · 9999999995-16-006547
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2016-12-23 · 0001193125-16-803074
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2016-11-15 · 0001193125-16-769043
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2016-11-15 · 0001193125-16-769036
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2016-11-15 · 0001193125-16-769031
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2016-09-28 · 0001193125-16-721766
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2016-09-27 · 0001193125-16-721760
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2016-06-09 · 0001193125-16-617739
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
2016-05-13 · 0001193125-16-590548
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B3 and marks the registration effective.
2016-04-29 · 9999999995-16-004448
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2016-04-22 · 0001193125-16-551834
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2016-04-20 · 0001193125-16-548154
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
variable and index-linked deferred annuity contract · Exchange NASDAQ · Underwriters AXA Advisors, LLC, AXA Distributors, LLC
2016-04-20 · 0001193125-16-548124
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows RW and confirms the priced prospectus.
2016-04-19 · 0001193125-16-546541
RW
withdrawn
Withdrawal request
Issuer requested withdrawal of the registration statement.
Follows EFFECT and ends the active registration process.
2016-03-24 · 0001193125-16-516337
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B3 and marks the registration effective.
2016-03-22 · 9999999995-16-004021
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2016-02-19 · 0001193125-16-469748
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2016-02-19 · 0001193125-16-469747
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2016-02-19 · 0001193125-16-469746
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
Structured Capital Strategies(R) 16 · Exchange NASDAQ · Underwriters AXA Advisors, LLC, AXA Distributors, LLC
2016-01-28 · 0001193125-16-442084
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
variable and index-linked deferred annuity contract · Exchange NASDAQ · Underwriters AXA Advisors, LLC, AXA Distributors, LLC
2016-01-05 · 0001193125-16-421461
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B3 and marks the registration effective.
2015-12-29 · 9999999995-15-003420
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
Use of proceeds To modify guaranteed benefits and associated charges
2015-10-30 · 0001193125-15-360332
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2015-08-24 · 0001193125-15-300012
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2015-08-24 · 0001193125-15-300011
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2015-07-24 · 0001193125-15-262422
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2015-07-17 · 0001193125-15-255846
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2015-07-17 · 0001193125-15-255835
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2015-07-17 · 0001193125-15-255830
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2015-07-17 · 0001193125-15-255822
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
Use of proceeds To increase contract account values by terminating guaranteed benefits
2015-07-07 · 0001193125-15-246647
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2015-05-01 · 9999999995-15-001176
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B3 and marks the registration effective.
2015-04-29 · 9999999995-15-001060
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
Deferred annuity contract
2015-04-22 · 0001193125-15-141629
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
Gross proceeds $50,000,000
Escrow Shield Plus Agreement · Use of proceeds To provide an alternative to escrow accounts in mergers and acquisitions, preserving principal while earning interest · Underwriters AXA Distributors, LLC
2015-04-22 · 0001193125-15-141364
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2015-04-21 · 0001193125-15-140135
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2015-04-16 · 0001193125-15-133171
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
2015-01-07 · 0001193125-15-003742
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B3 and marks the registration effective.
2014-12-30 · 9999999995-14-003908
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2014-12-15 · 0001193125-14-442710
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2014-11-20 · 0001193125-14-419615
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2014-11-07 · 0001193125-14-402930
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
2014-10-15 · 0001193125-14-372620
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B3 and marks the registration effective.
2014-08-18 · 9999999995-14-002541
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2014-08-18 · 0001193125-14-313002
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2014-08-18 · 0001193125-14-313000
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
2014-08-13 · 0001193125-14-308159
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B3 and marks the registration effective.
2014-08-01 · 9999999995-14-002361
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
2014-04-25 · 0001193125-14-159316
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2014-04-23 · 9999999995-14-001101
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2014-04-23 · 9999999995-14-001100
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B3 and marks the registration effective.
2014-04-23 · 9999999995-14-001099
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2014-02-19 · 0001193125-14-058711
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2014-02-18 · 0001193125-14-057338
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2014-01-17 · 0001193125-14-014132
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2013-12-20 · 0001193125-13-480778
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2013-12-10 · 0001193125-13-467846
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2013-11-15 · 0001193125-13-443750
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2013-11-12 · 0001193125-13-438191
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current filing provides a supplement to variable life and variable annuity prospectuses, updating information about the AXA Premier VIP Trust. It notes a sub-adviser name change for the Multimanager Aggressive Equity Portfolio, with GCIC US Ltd. rebranded as Scotia Institutional Asset Management US, Ltd.
2013-11-12 · 0001193125-13-437556
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current 424B3 filing serves as a supplement to variable life and variable annuity prospectuses, updating information about the AXA Premier VIP Trust's portfolios. A key change involves the renaming of a sub-adviser, GCIC US Ltd., to Scotia Institutional Asset Management US, Ltd., effective immediately. The filing emphasizes that other prospectus details remain unchanged and advises readers to retain this supplement for reference.
2013-11-12 · 0001193125-13-437525
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current 424B3 filing updates the prospectus for AXA Equitable Life Insurance Company's Incentive Life Legacy II and Optimizer II products, focusing on modifications to the Long-Term Care Services Rider available in New York. Key updates include the removal of Rider Form No. R11-80NY from availability, revised eligibility and coverage terms, and changes to maximum monthly benefit calculations and fixed paid-up options.
2013-09-27 · 0001193125-13-381761
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current filing is a supplement to variable annuity prospectuses for AXA Equitable Life Insurance Company, providing updated information for Florida residents. It outlines a 21-day cancellation period for variable annuity contracts, allowing policyholders to receive a refund based on the greater of the cash surrender value or total contributions paid.
2013-09-24 · 0001193125-13-375682
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The filing provides a supplement to variable annuity prospectuses, focusing on Florida residents. It outlines a 21-day cancellation period for annuity contracts, allowing policyholders to receive a refund equal to the greater of the cash surrender value or total contributions paid.
2013-09-24 · 0001193125-13-375678
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current filing is a supplement to variable annuity prospectuses, focusing on Florida residents' rights to cancel their contracts and receive refunds. It updates information from a previous filing that introduced the ProNvest Managed Account Service, which allows enrollment in managed account services through a third party, with associated fees and restrictions on asset transfers.
2013-09-24 · 0001193125-13-375675
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current 424B3 filing supplements the prospectus for AXA Equitable's structured investment options, introducing the ProNvest Managed Account Service. This service allows participants to enroll in automated asset allocation managed by ProNvest, Inc., with specific fee structures and restrictions on transfers. The filing also includes detailed examples of Segment Interim Value calculations, though the primary change from the previous filing is the addition of ProNvest's managed account service and its associated terms.
2013-09-13 · 0001193125-13-366187
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current filing supplements the prospectus for Equitable Financial Life Insurance Co.'s Structured Investment Option, adding 3-year and 5-year segments tied to the S&P 500 Price Return Index with a -20% buffer. It replaces Appendix I with detailed examples of Segment Interim Value calculations under various market scenarios, effective September 23, 2013, pending regulatory approval.
2013-09-06 · 0001193125-13-359949
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
Use of proceeds The company offers to increase the contract's account value in exchange for terminating guaranteed benefits.
The current filing offers contract holders the opportunity to terminate guaranteed minimum income, death, and earnings enhancement benefits in exchange for an increased account value and potential exchange for other annuity contracts. The offer amount is calculated based on actuarial valuations and market conditions, with termination of benefits being irreversible.
2013-08-28 · 0001193125-13-350504
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current 424B3 filing updates the prospectus for AXA Equitable Life Insurance Company's variable life insurance policies, focusing on modifications to investment options and transfer policies. It introduces an unrestricted transfer period from the Guaranteed Interest Option (GIO) through March 31, 2014, and outlines changes to sub-advisers and portfolio names within the EQ Advisors Trust. The supplement also highlights restrictions on transfers involving policy loans or living benefits.
2013-08-21 · 0001193125-13-341786
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current 424B3 filing serves as a semi-annual report supplement updating the variable annuity prospectuses for AXA Equitable Life Insurance Company and MONY Life Insurance Company of America. It outlines additions of sub-advisers to specific EQ Advisors Trust portfolios, name changes for certain investment options, and a update regarding the Defense of Marriage Act (DOMA) following the U.S. Supreme Court's ruling on same-sex marriage recognition.
2013-08-21 · 0001193125-13-341704
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
The 424B3 filing updates the variable annuity prospectuses for AXA Equitable Life Insurance Company and MONY Life Insurance Company of America. It details additions of sub-advisers to specific portfolios, name changes for certain investment options, and a summary of the impact of the U.S. Supreme Court's DOMA ruling on tax treatment for same-sex spouses.
2013-08-21 · 0001193125-13-341687
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B3 and marks the registration effective.
The filing confirms the effectiveness of AXA Equitable Life Insurance Company's Market Stabilizer Option, an investment feature tied to the S&P 500 Price Return index for certain variable life insurance policies. The option offers potential returns based on index performance but includes significant risks, including principal loss. The document emphasizes risks such as negative returns, early distribution penalties, and reliance on third-party indices.
2013-04-26 · 9999999995-13-001166
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current filing details the Market Stabilizer Option, a variable life insurance feature tied to the S&P 500 Price Return index. It outlines terms like Index-Linked Return, Early Distribution Adjustments, and risks including potential principal loss. The document emphasizes that returns are subject to market performance, with protections and limitations specified.
2013-04-25 · 0001193125-13-173947
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
variable and fixed deferred annuity contract
The current filing is a prospectus for AXA Equitable's Accumulator(R) Series deferred annuity contracts, emphasizing tax-deferred retirement savings accumulation with variable and fixed investment options. It highlights limited contribution acceptance (QP contracts and Florida residents only) and details benefits like guaranteed withdrawal and principal guarantees. Previous filing focused on EQUI-VEST(R) employer-sponsored retirement plans, a distinct product line.
2013-04-24 · 0001193125-13-170404
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current filing is a prospectus for Equitable Financial Life Insurance Co's EQUI-VEST(R) deferred annuity contract, designed for employer-sponsored retirement plans. It outlines investment options, fees, and risks, with new variable investment options scheduled for availability in May 2013. The document emphasizes that the SEC has not approved the securities and highlights risks including potential loss of principal and state-specific availability.
2013-04-23 · 0001193125-13-167510
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The filing updates the variable life and variable annuity prospectuses to reflect a change in the sub-advisers for the Multimanager Aggressive Equity Portfolio. Legg Mason Capital Management, LLC is no longer a sub-adviser, while several other firms remain. The supplement emphasizes that all other prospectus information remains unchanged.
2013-02-15 · 0001193125-13-062228
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current filing updates the Prospectus for variable life and annuity products, reflecting changes to the Multimanager Aggressive Equity Portfolio's sub-advisers and adjustments to the Performance Cap Rate for the Structured Investment Option. Legg Mason Capital Management, LLC is no longer a sub-adviser, while other firms remain. The Performance Cap Rate threshold for establishing Segments in the SIO was reduced, effective April 1, 2013.
2013-02-15 · 0001193125-13-062223
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current filing updates information related to variable deferred annuity prospectuses for Equitable Financial Life Insurance Co. It includes changes to the Structured Investment Option (SIO) performance cap rate thresholds and a sub-adviser change for the Multimanager Aggressive Equity Portfolio. The supplement emphasizes that other prospectus details remain unchanged.
2013-02-15 · 0001193125-13-062202
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The supplement updates prospectuses for variable life and annuity products, noting changes to sub-advisers of the Multimanager Aggressive Equity Portfolio and adjustments to the Performance Cap Rate for the Structured Investment Option. It also mentions a temporary relaxation of transfer rules for the Guaranteed Interest Option.
2013-02-15 · 0001193125-13-062182
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current 424B3 filing updates the prospectus for AXA Equitable variable life insurance policies, focusing on relaxing restrictions for transferring funds out of the Guaranteed Interest Option (GIO) through September 30, 2013. It allows unrestricted transfers of unloaned account values from GIO to other investment options, regardless of the GIO Transfer Period, with specific deadlines and limitations. The filing also reaffirms that other prospectus information remains unchanged.
2013-02-08 · 0001193125-13-045059
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current filing updates the Long-Term Care Benefits Rider for the Incentive Life Optimizer product, replacing the prior version with revised terms. It outlines eligibility, benefit structures, elimination periods, and lien mechanisms for long-term care services. The supplement emphasizes changes to how benefits are calculated, including monthly payments, maximum limits, and policy value adjustments during coverage periods.
2013-02-07 · 0001193125-13-043414
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current filing updates investors on portfolio substitutions for variable investment options under AXA Equitable's Accumulator and Income Manager products, effective May 20, 2013. It details the replacement of specific portfolios with new ones, clarifies tax implications, and notes that AXA Equitable will bear substitution costs. The supplement also provides details on how these changes affect contract holders, including automatic reallocation of contributions and rebalancing elections.
2013-02-04 · 0001193125-13-035998
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current 424B3 filing supplements the prospectus for Equitable Financial Life Insurance Co., introducing three new variable investment options: AXA Tactical Manager 400, AXA Tactical Manager 2000, and EQ/AllianceBernstein Short Duration Government Bond. These options, subject to regulatory approval, are available for specific insurance products like Accumulator and Income Manager. The supplement highlights investment managers and sub-advisers for the new portfolios, emphasizing their objectives and risk-adjusted return strategies.
2012-12-10 · 0001193125-12-497155
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
The current 424B3 filing serves as a supplement to the prospectus for AXA Equitable's Structured Capital Strategies ®, effective November 12, 2012. It modifies the prospectus by waiving withdrawal charges for qualifying institutional clients purchasing Series B contracts, with all other prospectus information remaining unchanged.
2012-11-13 · 0001193125-12-467153
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B3 and marks the registration effective.
The current filing announces the effectiveness of a prospectus supplement for AXA Equitable Life Insurance Company's variable annuity contracts. It outlines an optional offer to terminate guaranteed minimum death benefits (GMDB) and earnings enhancement benefits (EEB) in exchange for an increase in contract account value. The supplement provides detailed terms, including actuarial calculations for offer amounts and risks associated with relinquishing guaranteed benefits.
2012-09-05 · 9999999995-12-002656
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current filing is a supplement to prospectuses for variable annuity contracts, offering contract holders the option to terminate guaranteed minimum death benefits (GMDB) and earnings enhancement benefits (EEB) in exchange for an increase in their contract's account value. The offer is time-sensitive and involves actuarial calculations to determine the offer amount, which depends on factors like account value, market conditions, and life expectancy. Accepting the offer terminates the GMDB, EEB, and standard death benefit, replacing them with a return-of-account-value death benefit.
2012-08-31 · 0001193125-12-377482
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current filing supplements the prospectus for AXA Equitable Life Insurance Company's Structured Investment Option under the EQUI-VEST(R) Employer-Sponsored Retirement Plans. It clarifies availability for the EQUI-VEST(R) VANTAGE/SM/ ACTS Program in New Jersey, updates definitions, modifies risk factors related to Segment creation, and adjusts charge disclosures. The supplement replaces prior materials for participants.
2012-08-15 · 0001193125-12-357091
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The filing supplements the prospectus for Equitable Financial Life Insurance Co's EQUI-VEST(R) Employer-Sponsored Retirement Plan, focusing on the Structured Investment Option. It details charges, transfer restrictions, and expenses related to this investment feature, while also outlining the EQUI-VEST(R) Vantage/SM/ ACTS contract's terms, including fee structures, portfolio management, and tax considerations. The document emphasizes modifications to fee tables, administrative charges, and risks associated with market volatility and investment strategies.
2012-08-15 · 0001193125-12-357088
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current 424B3 filing updates the prospectus for AXA Equitable's EQUIVEST products, modifying the 'Deposit option for NQ contracts only' section. This supplement replaces the previous filing, which addressed transfer policies for variable life insurance. The current update focuses on deposit options for policyholders, while the prior filing highlighted temporary flexibility in transferring funds from the Guaranteed Interest Option.
2012-08-02 · 0001193125-12-330825
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current filing updates the prospectus for variable life insurance policies, introducing a limited-time opportunity for unrestricted transfers from the Guaranteed Interest Option (GIO) to other investment options. This change, effective through March 29, 2013, allows policyholders to transfer unloaned account values without being restricted to the GIO Transfer Period. The supplement also outlines procedures for initiating transfers and notes potential charges or restrictions on certain amounts.
2012-08-01 · 0001193125-12-328500
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current filing updates the prospectus for AXA Equitable Life Insurance Company and MONY Life Insurance Company of America, announcing the addition of Lord Abbett & Co. LLC as a sub-adviser to the Multimanager Mid Cap Value Portfolio, effective June 18, 2012. Other sub-advisers and the investment manager remain unchanged.
2012-06-20 · 0001193125-12-277170
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current 424B3 filing supplements the prospectus for AXA Equitable Life Insurance Company and MONY Life Insurance Company of America, effective June 20, 2012. It announces the addition of Lord Abbett & Co. LLC as a sub-adviser to an allocated portion of the Multimanager Mid Cap Value Portfolio, with existing investment managers and sub-advisers remaining unchanged. The update emphasizes that other prospectus details remain unaffected.
2012-06-20 · 0001193125-12-277163
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
The current 424B3 filing supplements the prospectus for AXA Equitable Life Insurance Company and Mony Life Insurance Company of America, effective June 20, 2012. It primarily updates information related to the Multimanager Mid Cap Value Portfolio, adding Lord Abbett & Co. LLC as a sub-adviser effective June 18, 2012, while retaining existing sub-advisers and the investment manager.
2012-06-20 · 0001193125-12-277155
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B3 and marks the registration effective.
The current filing announces the effectiveness of AXA Equitable Life Insurance Co.'s S-3 registration statement for the Accumulator(R) Series, a deferred annuity product offering variable and fixed investment options. The prospectus outlines contract features, including investment choices, death and income benefits, and payout options, while noting restrictions on new contributions except for specific contracts and states.
2012-04-30 · 9999999995-12-001291
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
The 424B3 filing serves as a prospectus for AXA Equitable's Accumulator(R) Series, a range of deferred annuity contracts offering variable and fixed investment options. The document outlines key features such as investment portfolios, death and income benefits, and withdrawal options, while noting restrictions on new contributions except for specific qualified plans (QP) and Florida contracts. It emphasizes risks, including market volatility and lack of FDIC insurance, and references updated portfolio names effective May 1, 2012.
2012-04-25 · 0001193125-12-181266
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B3 and marks the registration effective.
The SEC has declared the registration effective for AXA Equitable Life Insurance Co's S-3 filing, which relates to the EQUI-VEST(R) deferred annuity contract for employer-sponsored retirement plans. The prospectus outlines variable investment options, guaranteed interest, and fixed maturity options, emphasizing risks associated with market fluctuations and principal loss. The document supersedes prior disclosures and includes updated investment portfolio names effective May 1, 2012.
2012-04-24 · 9999999995-12-001149
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
Deferred annuity contract issued by AXA Equitable Life Insurance Company · Use of proceeds Not applicable as this is a prospectus for a variable annuity product
The current 424B3 filing serves as a prospectus for AXA Equitable's EQUI-VEST(R) variable annuity contract, designed for employer-sponsored retirement plans. It outlines investment options, fee structures, and contractual features, emphasizing tax-deferred growth, death benefits, and payout options. The document supersedes prior disclosures and includes details on variable investment portfolios, guaranteed interest options, and regulatory compliance.
2012-04-24 · 0001193125-12-178195
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current 424B3 filing updates the prospectus for AXA Equitable variable life insurance policies, focusing on temporary relaxation of restrictions for transferring funds out of the Guaranteed Interest Option (GIO). Policyholders can now transfer any unloaned account value from the GIO to other investment options until September 30, 2012, subject to potential charges and exceptions for collateral or restricted amounts.
2012-02-06 · 0001193125-12-040577
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
This 424B3 filing serves as a supplement to existing variable life and variable annuity prospectuses, updating information related to the EQ Advisors Trust. The primary change involves a sub-adviser name update from Goodman & Co. NY Ltd to GCIC US Ltd for the Multimanager Aggressive Equity Portfolio. The document emphasizes that other prospectus information remains unchanged.
2012-02-06 · 0001193125-12-040546
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current filing updates the prospectus for AXA Equitable Life Insurance Company, focusing on a sub-adviser name change within a portfolio. It confirms that other information in the prospectus remains unchanged and emphasizes the need to review the supplement alongside the prospectus.
2012-02-06 · 0001193125-12-040520
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
AXA Equitable Life Insurance Company is notifying contract holders of its Accumulator variable annuity that it will suspend acceptance of additional contributions as of February 17, 2012, due to the current economic environment characterized by low interest rates and high market volatility. The change affects future contributions but does not impact existing investments or guaranteed benefits.
2011-12-27 · 0001193125-11-352854
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B3 and marks the registration effective.
The Notice of Effectiveness confirms the activation of an S-3 filing for AXA Equitable Life Insurance Co, updating the prospectus for the EQUI-VEST Strategies/SM Series 901 and Structured Investment Option. Key changes include revised loan provisions, fee adjustments, and updated contract features, effective October 24, 2011.
2011-10-21 · 9999999995-11-003023
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current 424B3 filing updates the prospectus for AXA Equitable's EQUI-VEST(R) Strategies/SM (Series 901) and Structured Investment Option, focusing on revised loan provisions, fee structures, and death benefit calculations. Key changes include replacing the loan framework for contracts issued after October 24, 2011, adding administrative fees for loans, and modifying how account values and death benefits are calculated.
2011-10-21 · 0001193125-11-276858
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current 424B3 filing serves as a supplement to the prospectus for AXA Equitable's Structured Capital Strategies, updating state-specific provisions and contractual terms. Key modifications include revised cancellation policies for New York residents, updated disability qualification criteria, and clarifications on ownership transfers. The filing emphasizes changes to refund calculations, annuity payout options, and re-certification requirements for disability benefits.
2011-09-28 · 0000089024-11-000523
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
This supplement updates information in the prospectuses for AXA Equitable and MONY America, detailing changes to portfolio sub-advisers and reduced annual expenses for specific investment options. It emphasizes that other prospectus information remains unchanged.
2011-08-18 · 0000089024-11-000497
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current filing is a supplement to the prospectus for AXA Equitable and MONY America, updating information about changes to sub-advisers for specific investment portfolios and a reduction in the highest annual portfolio expense for the Templeton Developing Markets Securities Portfolio. It also notes that certain variable investment options may not be available in all contracts.
2011-08-17 · 0000089024-11-000485
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current 424B3 filing updates prospectus information for AXA Equitable's variable life insurance policies, focusing on temporary changes to guaranteed interest option (GIO) transfer rules, portfolio sub-adviser adjustments, and a reduced expense ratio for a specific portfolio. It contrasts with the previous June 2011 filing, which addressed Illinois civil union policy provisions.
2011-08-16 · 0000089024-11-000470
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current 424B3 filing updates the prospectus for Illinois policies issued by AXA Equitable Life Insurance Company and MONY Life Insurance Company of America. It clarifies that Illinois law now treats civil union partners identically to married spouses for policy purposes, expanding definitions of 'married' and 'spouse' to include civil union participants. However, it does not address federal tax implications, unlike the previous filing which explicitly noted limitations under federal law.
2011-06-30 · 0000089024-11-000423
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The filing updates prospectus information for Illinois-based variable annuity contracts, addressing the legal treatment of civil unions under Illinois law versus federal tax law. It clarifies that while Illinois law treats civil union partners similarly to married spouses, federal tax benefits like spousal continuation are restricted due to the Defense of Marriage Act (DOMA).
2011-06-30 · 0000089024-11-000406
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
This 424B3 filing serves as a supplement to variable annuity prospectuses, updating information for contracts issued in Illinois. It clarifies that Illinois law now treats civil union spouses identically to married spouses under state law, but notes that federal tax benefits (e.g., spousal continuation) remain restricted due to the Defense of Marriage Act. The document also references distribution affiliates for certain contracts.
2011-06-30 · 0000089024-11-000389
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B3 and marks the registration effective.
Equitable Financial Life Insurance Co. filed a Notice of Effectiveness for its S-3 registration statement, effective April 29, 2011. The filing details the Structured Capital Strategies(SM) variable and index-linked deferred annuity contract, offering investment options tied to indices like the S&P 500 and commodities, with risks including principal loss and market volatility.
2011-04-29 · 9999999995-11-001297
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
Underwriters AXA Advisors, LLC, AXA Distributors, LLC
The current filing is a prospectus for AXA Equitable's Structured Capital Strategies(SM), a variable and index-linked deferred annuity contract. It offers retirement savings accumulation with payout options, investing in variable investment options or the Structured Investment Option tied to indices. The document emphasizes risks, including potential principal loss, withdrawal penalties, and limitations on investment flexibility. It also notes the availability of the product in specific states and variations in features.
2011-04-26 · 0000089024-11-000268
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current 424B3 filing details the Incentive Life Optimizer(R) II, a variable life insurance policy issued by AXA Equitable, offering death benefits and investment options including the Market Stabilizer Option(R) tied to the S&P 500 index. It replaces the previous EQUI-VEST(R) prospectus, which focused on employer-sponsored retirement annuities. The filing emphasizes tax-deferred growth, flexible premium payments, and risks associated with market volatility and early withdrawal penalties.
2011-04-25 · 0000089024-11-000233
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current filing is a prospectus for AXA Equitable's EQUI-VEST(R) deferred annuity contract, detailing investment options, risks, and features. It supersedes prior documents and includes updates to variable investment portfolios, sub-adviser changes, and name modifications. The filing emphasizes tax-deferred retirement savings with death benefit protections and outlines material provisions subject to future supplements.
2011-04-25 · 0000089024-11-000231
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The filing updates prospectus information for AXA Equitable's variable life insurance policies, focusing on changes to investment options and tax-related disclosures. Key updates include relaxing transfer rules for the Guaranteed Interest Option (GIO) and modifying portfolio objectives, sub-advisers, and names for certain investment options. Tax information is revised to reflect estate, gift, and generation-skipping tax implications.
2011-02-10 · 0000089024-11-000080
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current filing updates investment objectives, sub-adviser relationships, and portfolio names for certain investment options offered by AXA Equitable Life Insurance Company. Key changes include revised objectives for the EQ/Core Bond Index Portfolio, sub-adviser replacements for multiple portfolios, and renaming of the EQ/BlackRock International Value Portfolio to EQ/International Value PLUS. These updates are part of ongoing adjustments to the investment strategies and management structures of the Trusts.
2011-02-09 · 0000089024-11-000061
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current filing updates portfolio details for Equitable Financial Life Insurance Co's variable annuity products, including changes to investment objectives, portfolio names, and sub-adviser relationships. Key updates include renaming the EQ/BlackRock International Value Portfolio to EQ/International Value PLUS, replacing sub-advisers for multiple portfolios, and adjusting fee structures for certain investment options. These changes affect various Equi-Vest series and retirement plans.
2011-02-09 · 0000089024-11-000048
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The filing updates the variable annuity prospectuses for AXA Equitable Life Insurance Company, effective January 1, 2011. Key changes include permitting partial annuitization of nonqualified deferred annuity contracts with life-contingent or 10+ year period-certain payouts, and revised Florida-specific provisions for free look periods and withdrawal charges. Tax implications of partial annuitization and its impact on guaranteed benefits are detailed.
2010-12-29 · 0000089024-10-000645
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The filing updates the variable annuity prospectuses for AXA Equitable Life Insurance Company, effective January 1, 2011. Key changes include permitting partial annuitization of nonqualified deferred annuity contracts with life-contingent or 10+ year period-certain payouts, and modifying Florida's free look period and withdrawal charge rules. Tax implications and withdrawal charge structures are also addressed.
2010-12-29 · 0000089024-10-000641
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current 424B3 filing updates variable annuity prospectuses to reflect changes effective January 1, 2011, including permitting partial annuitization of nonqualified deferred annuity contracts under specific conditions and modifying Florida's free look period and withdrawal charge rules. It supersedes prior disclosures about Structured Capital Strategies, which focused on defined benefit plan investments.
2010-12-29 · 0000089024-10-000634
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current 424B3 filing supplements the prospectus for AXA Equitable's Structured Capital Strategies(SM) product, adding Appendix V to address defined benefit plan trustee considerations. This update permits pooled defined benefit plan assets to purchase non-qualified contracts, outlines liquidity requirements (80% in the product, 20% in other vehicles), and highlights suitability and tax compliance risks. The document emphasizes that the product is not 'benefit friendly' and requires careful evaluation by plan trustees.
2010-12-15 · 0000089024-10-000619
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current 424B3 filing serves as a supplement to the prospectus for AXA Equitable Life Insurance Company's Structured Capital Strategies(SM), incorporating state-specific updates and contract term modifications. Key changes include Oregon's restrictions on post-fifth-year contributions, Puerto Rico's tax exemptions, and revised withdrawal charge policies. The document also clarifies annuity payout timing and assignment rules.
2010-12-06 · 0000089024-10-000614
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current filing updates the prospectus for AXA Equitable Life Insurance Company and MONY Life Insurance Company of America, focusing on changes to the EQ/AllianceBernstein International Portfolio. The supplement clarifies the portfolio's investment objective, which now aims to track specific international indices, and includes revised fee structures. It also notes the continued roles of AllianceBernstein L.P. as sub-adviser and AXA Equitable as investment manager.
2010-11-23 · 0000089024-10-000606
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The filing updates the prospectus for AXA Equitable Life Insurance Company's EQ/AllianceBernstein International Portfolio, detailing changes to fee structures and investment objectives. The supplement clarifies the portfolio's fee table, revises its investment strategy to track specific international indices, and confirms ongoing roles of AllianceBernstein L.P. as sub-adviser and AXA Equitable as investment manager.
2010-11-23 · 0000089024-10-000593
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current filing updates the investment objective of the EQ/AllianceBernstein International Portfolio, aligning it with specific global indices. It confirms the continued roles of AllianceBernstein L.P. as the sub-adviser and AXA Equitable Life Insurance Company as the investment manager. The supplement emphasizes that other prospectus details remain unchanged.
2010-11-23 · 0000089024-10-000583
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The filing details the Market Stabilizer Option (MSO) offered by AXA Equitable Life Insurance Company, an investment feature tied to the S&P 500 Price Return index. The MSO provides returns based on index performance, with a Growth Cap Rate and Downside Protection of -25%. Key terms include Index-Linked Returns applied at the Segment Maturity Date, Early Distribution Adjustments for premature withdrawals, and risks of principal loss. The document emphasizes that the SEC has not approved the securities and highlights significant investment risks.
2010-11-16 · 0000089024-10-000572
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
The current 424B3 filing serves as a supplement to the prospectus for AXA Equitable's Structured Capital Strategies(SM), correcting three instances where the term 'decreases' was replaced with 'increases' to ensure accuracy in product descriptions. This update modifies specific sections of the prospectus, including risk factors and investment features, without altering other fundamental information. The filing emphasizes the importance of reviewing the supplement alongside the prospectus for updated details.
2010-10-07 · 0000089024-10-000538
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B3 and marks the registration effective.
The Notice of Effectiveness confirms the effectiveness of AXA Equitable Life Insurance Co's S-3 registration statement, allowing the company to offer securities. This follows a prospectus supplement (424B3) dated August 25, 2010, which updated information about investment portfolios, distribution arrangements, and policy transfer policies.
2010-09-21 · 9999999995-10-002744
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current filing updates prospectus information for various AXA Equitable variable life insurance policies, focusing on two key changes: (1) temporary relaxation of restrictions on transferring funds out of the Guaranteed Interest Option (GIO) through March 2011, allowing unrestricted transfers outside of scheduled GIO transfer periods, and (2) modifications to investment portfolios including sub-adviser changes, revised investment objectives for AXA Tactical Manager portfolios, and updated distribution fee disclosures. The document also notes potential transfer charges and restrictions on collateralized or restricted policy amounts.
2010-09-07 · 0000089024-10-000508
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current filing updates prospectuses for Equitable Financial Life Insurance Co's variable annuity products, including changes to sub-advisers, new investment options, fee disclosures, and contact information. Key updates include replacing sub-advisers for certain portfolios, adding 16 new variable investment options for specific contracts, revising fee tables, and updating contribution contact details.
2010-08-26 · 0000089024-10-000499
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current 424B3 filing serves as a supplement to prospectuses for AXA Equitable's Accumulator series products, detailing updates to contract features, sub-adviser changes, and state-specific enhancements. Key updates include revised contribution processing procedures, the removal of AXA Rosenberg as a sub-adviser for a portfolio, and additions of guaranteed minimum benefits for Oregon contractholders. The filing also clarifies terms around automated processing and early distribution adjustments.
2010-08-24 · 0000089024-10-000463
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current filing is a prospectus for AXA Equitable's Incentive Life Optimizer(R) II, a flexible premium variable life insurance policy with investment options tied to mutual fund portfolios. It outlines policy features, risks, and details about the Market Stabilizer Option(SM), which links returns to the S&P 500 index. The document emphasizes that the SEC has not approved the securities and highlights risks such as market volatility, early withdrawal penalties, and tax implications.
2010-06-23 · 0000089024-10-000427
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current 424B3 filing serves as a supplement to the prospectus for AXA Equitable Life Insurance Company's products, focusing on a change to the sub-adviser of the EQ/Van Kampen Comstock Portfolio. Effective June 1, 2010, Invesco Advisers, Inc. replaced Morgan Stanley Investment Management, Inc. as the sub-adviser, while AXA Equitable remains the investment manager. The supplement updates prospectus information without altering other terms.
2010-06-15 · 0000089024-10-000405
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current filing updates the prospectus for AXA Equitable Life Insurance Company's investment products, focusing on a change in the sub-adviser for the EQ/Van Kampen Comstock Portfolio. Effective June 1, 2010, Invesco Advisers, Inc. replaced EQ Advisors Management, Inc. as the sub-adviser, with AXA Equitable retaining its role as Investment Manager. The supplement emphasizes that other prospectus details remain unchanged.
2010-06-15 · 0000089024-10-000401
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current filing is a prospectus for the Accumulator(R) Series, a deferred annuity contract issued by AXA Equitable Life Insurance Company. It outlines investment options, including variable portfolios, guaranteed interest, and fixed maturity options, alongside features like death benefits, income guarantees, and withdrawal protections. The document supersedes prior prospectuses and emphasizes risks associated with market performance and contract limitations.
2010-04-22 · 0000089024-10-000295
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
Combination variable and fixed deferred annuity contract
The current 424B3 filing for Equitable Financial Life Insurance Co. is a prospectus for the EQUI-VEST(R) Series 100-500 annuity contract, a variable and fixed deferred annuity. It outlines investment options, fees, risks, and features of the contract, emphasizing tax-deferred growth, death benefits, and payout options. The filing supersedes prior prospectuses and includes details about the Trusts and portfolios.
2010-04-19 · 0000089024-10-000243
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The filing provides details about the Market Stabilizer Option (MSO) offered by AXA Equitable Life Insurance Company, an investment feature tied to the S&P 500 Price Return index. It outlines terms such as index-linked returns, early distribution adjustments, and downside protection, emphasizing risks like potential principal loss and dependency on policy account reserves.
2010-04-01 · 0000089024-10-000204
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
The 424B3 filing details the Market Stabilizer Option (MSO) offered by AXA Equitable Life Insurance Company, an investment feature tied to the S&P 500 Price Return index. The MSO provides participation in index performance with a Growth Cap Rate, but includes risks such as potential negative returns, early distribution adjustments causing principal loss, and reliance on third-party indices. The document emphasizes that the SEC has not approved the securities and highlights significant investment risks.
2010-03-31 · 0000089024-10-000203
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B3 and marks the registration effective.
The current filing represents the effectiveness of AXA Equitable Life Insurance Co.'s S-3 registration statement, which includes prospectus supplements for variable annuities and employer-sponsored retirement plans. The supplements outline updated procedures for handling initial contributions, particularly for contracts sold through AXA Advisors, detailing holding periods, return conditions, and application processing timelines.
2010-03-29 · 9999999995-10-000865
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current 424B3 filing updates procedures for handling initial contributions to AXA Equitable variable annuities, specifically clarifying processes for contracts sold through AXA Advisors. It outlines how contributions are held in non-interest-bearing accounts during application review and specifies timelines for transferring funds or returning them if applications are incomplete. The supplement differentiates between contracts sold through AXA Advisors versus other broker-dealers like Chase Investment Services.
2010-02-08 · 0000089024-10-000116
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current 424B3 filing updates procedures for processing initial contributions to AXA Equitable Variable Annuities, specifically for contracts sold through AXA Advisors or Chase Investment Services. It outlines timelines for holding contributions in non-interest-bearing accounts while applications are reviewed, conditions for returning funds, and application processing timelines. The filing emphasizes changes to contribution handling protocols compared to prior disclosures.
2010-02-08 · 0000089024-10-000115
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current 424B3 filing updates the prospectus for AXA Equitable Life Insurance Company's EQUI-VEST(R) series, detailing changes to the sub-advisers of specific portfolios and a planned portfolio substitution effective April 2, 2010. BlackRock Investment Management, LLC replaces SSgA Funds Management, Inc. as the sub-adviser for several portfolios, and the Multimanager Large Cap Growth option will be replaced by the Multimanager Aggressive Equity option. The filing emphasizes that other prospectus information remains unchanged.
2010-02-01 · 0000089024-10-000051
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current filing is a supplement to the prospectus for AXA Equitable Life Insurance Company's investment products, effective February 1, 2010. It outlines changes to the sub-advisers of certain portfolios and a planned portfolio substitution in April 2010. The supplement updates investors on these modifications, emphasizing that other prospectus information remains unchanged.
2010-02-01 · 0000089024-10-000040
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current 424B3 filing serves as a supplement to the prospectus for AXA Equitable Life Insurance Company's EQUI-VEST(R) and related products, effective January 7, 2010. It outlines updates to the Portfolios of the AXA Premier VIP Trust, specifically the replacement of SSgA Funds Management, Inc. with AllianceBernstein L.P. as the sub-adviser for three portfolios. The investment manager, AXA Equitable, remains unchanged. The supplement emphasizes that other prospectus information remains valid.
2010-01-07 · 0000089024-10-000012
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
This supplement updates the prospectus for AXA Equitable Life Insurance Company's Accumulator products, reflecting a change in sub-advisers for specific portfolios effective December 28, 2009. The Investment Manager remains AXA Equitable, while AllianceBernstein L.P. now serves as the sub-adviser for certain portfolios previously managed by SSgA Funds Management, Inc.
2010-01-07 · 0000089024-10-000002
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current filing updates investment options for Equitable Financial Life Insurance Co., detailing the merger of the EQ/Caywood-Scholl High Yield portfolio into the EQ/Quality Bond PLUS portfolio with a 3% or 4% roll-up rate. It also allows transfers between investment options at any time. The filing references prior changes, including the removal of Firsthand Capital Management as a sub-adviser to the Multimanager Technology Portfolio, but focuses on current portfolio adjustments.
2009-09-25 · 0000089024-09-000618
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current 424B3 filing updates the prospectus for AXA Equitable Life Insurance Company's EQUI-VEST(R) and related retirement products, reflecting the removal of Firsthand Capital Management, Inc. as a sub-adviser to the Multimanager Technology Portfolio effective August 1, 2009. The supplement emphasizes that other sub-advisers remain unchanged and confirms the continued use of trademarks for various investment products.
2009-09-03 · 0000089024-09-000577
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current filing is a supplement to the prospectus for AXA Equitable Life Insurance Company's investment products, updating information related to sub-adviser changes and portfolio adjustments. It notes the removal of Firsthand Capital Management, Inc. as a sub-adviser to the Multimanager Technology Portfolio, with other sub-advisers remaining in place.
2009-09-03 · 0000089024-09-000576
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current filing updates the prospectus for Equitable Financial Life Insurance Co.'s EQUI-VEST(R) plans, detailing portfolio mergers, name changes, and the addition of a new investment option. Key changes include reorganizing existing portfolios into replacement options, renaming the EQ/Focus PLUS portfolio to EQ/Equity Growth PLUS, and introducing 'All Asset Allocation' as a new variable investment option. Fee structures and examples are adjusted to reflect reduced expenses.
2009-08-13 · 0000089024-09-000479
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current filing updates the prospectus for AXA Equitable Life Insurance Company's Accumulator products, detailing portfolio reorganizations, name changes, and fee adjustments. Key changes include mergers of existing portfolios into replacement options, name modifications for specific funds, and updates to fee structures. Shareholder approvals are required for certain portfolio reorganizations, with effective dates scheduled for September 2009.
2009-08-13 · 0000089024-09-000478
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The filing updates the prospectus for AXA Equitable Life Insurance Company's investment options, detailing portfolio name changes, sub-adviser replacements, and shifts to passive management strategies. Effective June 8, 2009, certain portfolios were renamed and restructured, with AllianceBernstein L.P. replacing OppenheimerFunds, Inc. as sub-adviser. The portfolios transitioned to passive strategies tracking Russell indices, reducing management fees. These changes apply to specific investment options within variable annuity contracts.
2009-06-16 · 0000089024-09-000396
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current 424B3 filing supplements the prospectus for AXA Equitable Life Insurance Company's investment options, detailing portfolio name changes, sub-adviser replacements, and strategy shifts. Effective June 2009, certain portfolios are renamed and managed by AllianceBernstein L.P. instead of OppenheimerFunds, Inc., transitioning to passive strategies tracking specific indices with reduced fees. The changes affect availability and management structure of investment options.
2009-06-16 · 0000089024-09-000395
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current filing for Accumulator(R) outlines a deferred annuity contract offering retirement savings accumulation and income options, with variable and fixed investment choices. It supersedes prior prospectuses and details investment options, fees, and benefits, emphasizing tax-deferred growth and death/benefit protections. The document highlights contractual terms, state-specific variations, and risks associated with market performance and principal loss.
2009-04-23 · 0000089024-09-000244
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current 424B3 filing is a prospectus for AXA Equitable's EQUI-VEST(R) deferred annuity contract, detailing investment options, fees, and features. It supersedes prior prospectuses and includes updates to portfolio names, sub-adviser relationships, and expense structures. The document emphasizes that the SEC has not approved the securities and highlights risks associated with market fluctuations and principal loss.
2009-04-20 · 0000089024-09-000192
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
This supplement updates the Accumulator(R) prospectus for AXA Equitable Life Insurance Company, effective January 15, 2009. Key changes include portfolio name adjustments, sub-adviser replacements, and revised expense limitations for investment options. The document also updates fee tables and example calculations to reflect these modifications.
2009-01-15 · 0000089024-09-000033
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
This supplement to the Equi-Vest prospectus outlines changes to portfolio names, sub-advisers, and fee structures for AXA Premier VIP Trust and EQ Advisors Trust. Key updates include renaming specific portfolios, replacing sub-advisers like AllianceBernstein with SSgA Funds Management, and revising expense limitations to include Acquired Fund Fees and Expenses. The fee table and example calculations were updated to reflect these changes, effective January 15, 2009.
2009-01-15 · 0000089024-09-000026
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
The 424B3 filing serves as a supplement to the prospectus for AXA Equitable's EQUI-VEST(R) products, detailing changes to portfolio names, sub-adviser relationships, and fee structures. It updates information regarding the AXA Premier VIP Trust and EQ Advisors Trust, including revised portfolio names, new sub-adviser appointments, and adjusted fee tables. The document emphasizes that other prospectus information remains unchanged.
2008-11-25 · 0000089024-08-000597
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
The Notice of Effectiveness for AXA EQUITABLE LIFE INSURANCE CO's S-3 registration statement, effective November 18, 2008. The filing confirms the effectiveness of the securities offering, with a previous filing on the same date but differing file numbers and minor formatting variations.
2008-11-18 · 9999999995-08-003414
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B3 and marks the registration effective.
The filing represents a notice of effectiveness for a Form S-3 registration statement, updating prospectus information for AXA Equitable Life Insurance Company's investment products. Key changes include portfolio name modifications, sub-adviser reallocations, fee adjustments, and updated processing office addresses for Accumulator(R) communications.
2008-11-18 · 9999999995-08-003413
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current 424B3 filing updates prospectus information for AXA Equitable Life Insurance Company's Accumulator(R) and related products, focusing on portfolio name changes, sub-adviser updates, fee table adjustments, and a processing office address change. It replaces outdated references to investment options and clarifies management structures for the Trusts. This supplement follows a prior filing related to EQUI-VEST(R) retirement programs, but the current updates are specific to portfolio restructurings and operational details.
2008-11-18 · 0000089024-08-000585
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current 424B3 filing updates the prospectus for AXA Equitable's EQUI-VEST(R) employer-sponsored retirement programs, focusing on state-specific changes to withdrawal charge calculations in Utah. It modifies the 'Fees and charges' section under 'EQUI-VEST(R) employer-sponsored retirement programs at a glance' to reflect adjusted withdrawal charge percentages for certain contract series effective August 25, 2008. This supplement does not alter other prospectus information unless otherwise indicated.
2008-08-20 · 0000089024-08-000483
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The filing updates expense limitation arrangements for certain portfolios of EQ Advisors Trust, effective October 1, 2008, with some exceptions. It details the elimination of expense limits for specific portfolios operating under their expense caps and amendments to others. Fee tables are revised to reflect updated management, 12b-1, and other expenses, including net expenses after waivers and reimbursements.
2008-08-14 · 0000089024-08-000455
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current filing updates expense limitation arrangements for portfolios within EQ Advisors Trust, effective October 1, 2008. It eliminates expense limits for certain portfolios and revises others, accompanied by a detailed fee table. This supplement modifies prior prospectuses but does not indicate significant structural or operational changes for the company.
2008-08-14 · 0000089024-08-000439
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current filing updates contact information for AXA Equitable Life Insurance Company, focusing on changes to processing office addresses for handling contributions and correspondence. It specifies new mailing addresses and delivery instructions for different types of transactions, emphasizing proper submission methods to avoid processing delays.
2008-08-13 · 0000089024-08-000433
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current 424B3 filing updates the processing office address for AXA Equitable Life Insurance Company and details changes to portfolio sub-advisers effective August 1, 2008. It modifies prospectus information regarding how customer correspondence is processed and replaces sub-adviser details for specific trust portfolios.
2008-08-11 · 0000089024-08-000418
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current 424B3 filing updates prospectus information for AXA Equitable Life Insurance Company's EQUI-VEST(R) retirement products, effective August 1, 2008. It details changes to sub-advisers managing specific portfolios within the AXA Premier VIP Trust, including the addition of Pacific Global Investment Management Company as a sub-adviser for the Multimanager Small Cap Value Portfolio. The supplement clarifies investment manager relationships and portfolio objectives for various retirement programs.
2008-07-25 · 0000089024-08-000400
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current filing updates the prospectuses for AXA Equitable Life Insurance Company's Accumulator products, focusing on changes to sub-advisers for the AXA Premier VIP Trust portfolios effective August 1, 2008. It replaces previous sub-adviser information for specific portfolios and notes the addition of Pacific Global Investment Management Company as a sub-adviser for the Multimanager Small Cap Value Portfolio as of July 14, 2008.
2008-07-25 · 0000089024-08-000399
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current 424B3 filing serves as a supplement to prospectuses for various AXA Equitable Life Insurance Company products, primarily addressing the relocation of the processing office in Secaucus, NJ. It updates contact information for correspondence and notes that other prospectus details remain unchanged. The filing emphasizes procedural updates rather than material financial or operational changes.
2008-06-20 · 0000089024-08-000352
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
The current 424B3 filing serves as a supplement to prospectuses for AXA Equitable Life Insurance Company's Equi-Vest products, modifying systematic withdrawal procedures. It clarifies how fixed-dollar withdrawals are deducted from variable investment options and guaranteed interest accounts, with specific restrictions for contracts offering fixed maturity options.
2008-05-30 · 0000089024-08-000340
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
The filing confirms the effectiveness of the S-1 registration statement for AXA EQUITABLE LIFE INSURANCE CO, dated April 30, 2008. This follows a previous post-effective amendment (POS AM) filing for the same company, indicating the registration is now effective for securities offering.
2008-04-30 · 9999999995-08-001345
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows S-1 and marks the registration effective.
The filing confirms the effectiveness of AXA Equitable Life Insurance Company's registration statement for additional market value adjustment interests under deferred variable annuity contracts. It incorporates by reference prospectuses from prior filings and outlines the offering of variable and fixed deferred annuity contracts, including investment options and payout structures.
2008-04-30 · 9999999995-08-001311
S-1
filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows 424B3 in the pre-IPO sequence.
200,000,000 shares · Gross proceeds $233,064,725
Flexible Premium Annuity Contracts · units of interest under annuity contracts · Use of proceeds for the issuance of annuity contracts
AXA Equitable Life Insurance Company is registering additional market value adjustment interests under its EQUI-VEST(SM) deferred variable annuity contracts. The filing includes a prospectus dated May 1, 2008, detailing investment options, fees, and contract features. The registration incorporates by reference prior prospectuses and the statement of additional information (SAI), with a focus on tax-deferred retirement savings and annuity payout options.
2008-04-21 · 0000089024-08-000173
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
This supplement updates prospectuses for AXA Equitable Life Insurance Company's 403(b) tax-sheltered annuity (TSA) contracts, reflecting changes under 2007 Treasury Regulations. Key updates include requirements for written 403(b) plans, restrictions on transactions without employer approval, and implications for older contracts issued before September 2007. The document emphasizes potential loss of 403(b) status for non-compliant contracts and details new rules around direct transfers, information sharing agreements, and Roth IRA rollover limitations.
2008-02-15 · 0000089024-08-000047
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The filing updates information regarding Tax-Sheltered Annuity (TSA) contracts under Section 403(b) of the IRS, reflecting changes due to 2007 Treasury Regulations. It highlights the potential loss of 403(b) status for pre-September 2007 contracts by 2009 unless employer actions are taken, restrictions on direct transfers, and requirements for employer-approved contributions and information sharing agreements.
2008-02-13 · 0000089024-08-000028
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current 424B3 filing from February 6, 2008, supplements the May 2007 prospectus for AXA Equitable Life Insurance Company's Accumulator products, introducing a new Guaranteed Withdrawal Benefit for Life (GWBL) rider. This update replaces the previous GWBL rider, modifies fee structures, and provides detailed terms for the GWBL, including changes to benefit base calculations, withdrawal charges, and restrictions. The filing emphasizes risks associated with excess withdrawals, account value fluctuations, and tax implications.
2008-02-06 · 0000089024-08-000018
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current filing introduces a new Guaranteed Withdrawal Benefit for Life (GWBL) rider for Accumulator products, replacing the previous GWBL rider. It outlines updated fee structures, including annual charges of 0.65% (Single Life) and 0.80% (Joint Life), with potential increases to 0.80% and 0.95% if the benefit base ratchets. The supplement also details GWBL features such as annual ratchets, 7% deferral bonuses, and restrictions on excessive withdrawals. It removes prior Puerto Rico-specific variations related to QP contracts and IRA availability.
2008-01-09 · 0000089024-08-000001
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
This filing supplements the prospectus for AXA Equitable Life Insurance Company's Accumulator products, focusing on Puerto Rico-specific restrictions for Qualified Plan (QP) contracts. It outlines limitations on contract ownership, contributions, and payments, along with tax and termination risks. Key additions include unavailability of IRA options, restrictions on employee additions, and potential taxable distributions upon plan termination.
2007-12-06 · 0000089024-07-000089
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current 424B3 filing serves as a supplement to the May 2007 prospectus for AXA Equitable's Accumulator variable annuity products, updating state-specific feature availability and benefit structures. Key changes include restrictions on certain contract features in Washington and Mississippi, adjustments to guaranteed minimum death benefit options, and modifications to administrative charges and withdrawal rules. The supplement emphasizes state-by-state variations in product offerings and clarifies terms related to benefit roll-up mechanisms and withdrawal penalties.
2007-11-15 · 0000089024-07-000082
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The filing updates prospectuses for variable annuity and life insurance products issued by AXA Equitable Life Insurance Company, MONY Life Insurance Company, and MONY Life Insurance Company of America. It notes a sub-adviser change effective October 1, 2007, where Wells Capital Management replaced Bear Stearns Asset Management as a sub-adviser to an allocated portion of the Multimanager Small Cap Growth Portfolio.
2007-10-19 · 0000089024-07-000054
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current filing updates prospectuses for variable annuity and life insurance products issued by AXA Equitable, MONY, and MONY America. It primarily notes a sub-adviser change for the Multimanager Small Cap Growth Portfolio, replacing Bear Stearns Asset Management with Wells Capital Management. Previous filings focused on state-specific adjustments, particularly in Oregon, regarding contract features, RMDs, and annuity payout options.
2007-10-19 · 0000089024-07-000034
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current 424B3 filing updates the prospectus for AXA Equitable's Accumulator(R) products, focusing on state-specific modifications in Oregon. Key changes include restrictions on required minimum distribution (RMD) processes, contribution limits, annuity commencement dates, and withdrawal charge policies. The supplement also deletes a section related to disability and terminal illness withdrawal charges.
2007-10-18 · 0000089024-07-000025
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
This supplement updates prospectuses for AXA Equitable Life Insurance Company's 403(b) contracts, addressing regulatory changes under Section 403(b) of the IRS code. It outlines the revocation of Revenue Ruling 90-24 effective January 1, 2009, with potential implications for tax-free transfers. Contracts issued before September 25, 2007, may be 'grandfathered' but face restrictions on future transactions unless tied to employer plans or information-sharing agreements. AXA Equitable will cease issuing 403(b) contracts after September 24, 2007, except through registered representatives.
2007-09-19 · 0000089024-07-000015
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The supplement updates information regarding 403(b) contracts under revised IRS regulations, effective January 1, 2009, revoking Revenue Ruling 90-24. It outlines tax implications for 'grandfathered' contracts and restrictions on future transactions. Additionally, it notes changes to withdrawal charges for certain IRA contracts in Illinois, specifying percentages based on contract years.
2007-09-19 · 0000089024-07-000009
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current 424B3 filing supplements the variable annuity prospectuses for AXA Equitable Life Insurance Company, updating withdrawal charge details for specific IRA contract series (Series 300, 400, and 800) effective September 24, 2007. The changes focus on Illinois-specific adjustments to withdrawal penalties for employer-sponsored retirement programs and individual IRA contracts.
2007-09-13 · 0000771726-07-000447
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current 424B3 filing supplements prospectuses for EQUI-VEST and At Retirement variable annuity contracts, adding details about eligible EQUI-VEST contract types that may be replaced. This follows a previous 424B3 filing addressing state-specific modifications to Accumulator contracts, including New Jersey and Texas adjustments.
2007-09-07 · 0000771726-07-000438
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current filing updates the prospectus for AXA Equitable Life Insurance Company's Accumulator products, incorporating changes to state-specific contract features and fund expense disclosures. Key modifications include the removal of New Jersey contract variations and an adjustment to the annual administrative charge in Texas. Additionally, the filing amends the expense limitation agreement for the Multimanager Core Bond Portfolio, capping total annual operating expenses at 1.00% for Class B shares effective October 1, 2007.
2007-09-07 · 0000771726-07-000423
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
This supplement updates the prospectuses for various AXA Equitable Life Insurance Company products, focusing on revised expense limitations for the Multimanager Core Bond Portfolio. Effective October 1, 2007, AXA Equitable agreed to waive or limit fees to ensure the portfolio's total annual operating expenses for Class B shares remain at 1.00%. The supplement amends tables detailing management fees, 12b-1 fees, and other expenses, with specific disclosures about fee waivers and potential reimbursements.
2007-08-24 · 0000771726-07-000411
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current 424B3 filing supplements prospectuses for various insurance products, focusing on expense adjustments for the Multimanager Core Bond Portfolio. Effective October 1, 2007, AXA Equitable waives fees to limit annual operating expenses for Class B shares to 1.00%, with revised fee tables and expense reimbursement details. No new products are introduced, but prior filings (e.g., September 2007) added a new variable investment option.
2007-08-24 · 0000771726-07-000410
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
Variable Investment Option in EQ/Van Kampen Real Estate Portfolio
The current 424B3 filing supplements the prospectus to add a new variable investment option, EQ/Van Kampen Real Estate, managed by Morgan Stanley Investment Management, Inc., with associated fees and examples. Other information remains unchanged.
2007-08-16 · 0000771726-07-000379
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current 424B3 filing by AXA Equitable Life Insurance Company updates the prospectus to extend the temporary liberalization period for allocations to the Guaranteed Interest Option (GIO) from 25% to 100% until April 30, 2008, with the 25% limit reinstating afterward. It warns of potential delays in crediting contributions if allocations exceed 25% after the period ends.
2007-08-09 · 0000771726-07-000355
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
Variable investment option investing in EQ Advisors Trust's common stock portfolio
The current filing supplements the prospectus for AXA Equitable's EQUI-VESTSM Vantage program, introducing a new variable investment option (EQ/AllianceBernstein Common Stock) under the EQ Advisors Trust. This addition includes updated fee structures and example calculations for the new portfolio, with no changes to other existing terms.
2007-07-17 · 0000771726-07-000343
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current filing is a prospectus for AXA Equitable's EQUI-VEST(SM) At Retirement(SM) deferred annuity contract, detailing its structure as a variable and fixed deferred annuity with investment options, death benefits, and income features. It outlines eligibility requirements, investment portfolios, and key terms for contracts under various retirement arrangements (IRA, TSA, NQ).
2007-07-13 · 0000771726-07-000339
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current filing is a supplement to the May 1, 2007 prospectus for Accumulator products, announcing the postponement of a portfolio substitution from July 9, 2007, to August 20, 2007, pending regulatory approval. The supplement emphasizes that other prospectus information remains unchanged.
2007-07-10 · 0000771726-07-000335
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current filing is a supplement to the May 1, 2007 prospectus for various Equitable Financial Life Insurance Co. products, including updates to portfolio substitution timelines and fixed maturity options. It includes a postponement of the July 9, 2007 substitution of variable investment options to August 20, 2007, pending regulatory approval, and updates to the Fixed Maturity Options Maturity Date Table. A separate supplement also addresses changes to contract features for Massachusetts residents.
2007-07-10 · 0000771726-07-000334
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current 424B3 filing supplements the May 2007 prospectus for Equitable Financial Life Insurance Co., focusing on modifications to insurance contracts and investment portfolios. Key updates include state-specific changes (e.g., Massachusetts contract variations), portfolio name adjustments, substitution of investment options, and merger activities. The filing also revises fee structures and investment manager details for various portfolios.
2007-06-27 · 0000771726-07-000313
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current filing updates the prospectus for Equitable Financial Life Insurance Co's investment portfolios, detailing name changes, substitutions, and mergers of several investment options. It includes adjustments to portfolio objectives, investment managers, and sub-advisers, along with revised fee structures and expense examples. Key changes include rebranding of portfolios, asset reorganizations, and modifications to administrative charges and transfer policies.
2007-06-05 · 0000771726-07-000303
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
The current 424B3 filing serves as a supplement to the May 1, 2007, prospectus for AXA Equitable's EQUI-VEST Employer-Sponsored Retirement programs, specifically modifying terms for TSA contracts related to the Detroit Board of Education. It highlights the waiver of the annual administrative charge, removing all references to such fees in the prospectus.
2007-06-01 · 0000771726-07-000301
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
The filing confirms the effectiveness of the S-1 registration statement for AXA EQUITABLE LIFE INSURANCE CO on May 1, 2007, at 11:30 A.M. The document appears identical to a previous filing on the same date, with only minor temporal differences in effectiveness timestamps (11:30 A.M. vs. 11:35 A.M.).
2007-05-01 · 9999999995-07-001638
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows S-1 and marks the registration effective.
The filing marks the effectiveness of a registration statement for AXA Equitable Life Insurance Company, registering additional market value adjustment interests under deferred variable annuity contracts. The document outlines the Accumulator(R) product, a deferred annuity offering variable and fixed investment options, and includes prospectus details. The company amended its previous registration to switch from Form S-3 to S-1 and delayed effectiveness as per SEC requirements.
2007-05-01 · 9999999995-07-001637
S-1
filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows S-1 in the pre-IPO sequence.
Market value adjustment interests under deferred variable annuity contracts · Use of proceeds No specific use of proceeds disclosed
Equitable Financial Life Insurance Co. is registering additional market value adjustment interests under deferred variable annuity contracts, specifically the Accumulator(R) and EQUI-VEST(SM) At Retirement(SM) products. The filing involves switching from Form S-3 to S-1 and includes details about variable and fixed investment options, tax-deferred growth, and payout structures. The prospectus is intended for existing contract owners, as the products are no longer available for new purchasers.
2007-04-27 · 0000771726-07-000173
S-1
filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows 424B3 in the pre-IPO sequence.
Market Value Adjustment Interests under Flexible Premium Annuity Contracts · Use of proceeds To update the prospectus and administrative costs
Equitable Financial Life Insurance Co. filed an S-1 registration statement to update the prospectus for market value adjustment interests under annuity contracts and transition from Form S-3 to S-1. The filing details the EQUI-VEST(SM) At Retirement(SM) deferred annuity, offering tax-deferred accumulation, investment options, and income benefits. It emphasizes that securities are not insured by FDIC or bank-guaranteed, with risks including market fluctuations and principal loss. The filing incorporates prior registration statements and outlines investment strategies, fees, and contractual features.
2007-04-27 · 0000771726-07-000172
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The filing updates prospectuses for variable life and annuity products, focusing on changes to the EQ/Small Company Growth Portfolio. AXA Equitable, as Investment Manager, appointed Wells Capital Management and Eagle Asset Management as additional advisers, increased administration fees, and revised portfolio management structure. The SEC exemptive order allows these changes without shareholder approval, with the Board of Trustees' oversight. The portfolio now involves multiple advisers managing allocated portions, impacting asset allocation and potential performance.
2006-12-14 · 0000771726-06-000597
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current filing updates prospectuses for variable life and annuity products, focusing on changes to the EQ/Small Company Growth Portfolio. Key updates include appointing Wells Capital Management and Eagle Asset Management as additional advisers, increasing administration fees, and revising portfolio fees and expenses. The filing also highlights the portfolio's investment strategies, risks, and management structure, with specific details on asset allocation and multiple advisers.
2006-12-14 · 0000771726-06-000587
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
Exchange NASDAQ
This filing updates the prospectus and statement of additional information (SAI) for AXA Equitable's Retirement Investment Account (RIA), effective February 28, 2007. Key changes include revised details about the AllianceBernstein Balanced Fund's investment strategies, portfolio managers, and risk disclosures, as well as modifications to asset allocation policies and restrictions on certain investments.
2006-12-13 · 0000771726-06-000584
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
Exchange NASDAQ
The filing updates the prospectus and statement of additional information (SAI) for the Retirement Investment Account (RIA), effective February 28, 2007. Key changes include revised details about the AllianceBernstein Balanced Fund's investment strategies, portfolio managers, and risk disclosures, along with modifications to asset allocation policies and fund restrictions.
2006-12-13 · 0000771726-06-000583
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
This filing supplements the May 1, 2006 prospectus and SAI for AXA Equitable's Members Retirement Program (MRP), effective February 28, 2007. It updates investment options for the AllianceBernstein Balanced Fund, detailing its objectives, investment strategies, portfolio managers, and asset allocation policies. Key changes include revised risk disclosures, hedging transaction policies, and modifications to mortgage-related securities and sovereign debt investments.
2006-12-13 · 0000771726-06-000582
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current 424B3 filing for Equitable Financial Life Insurance Co. updates the prospectus and statement of additional information (SAI) for the Members Retirement Program (MRP), effective February 28, 2007. Key changes include revised details for the AllianceBernstein Balanced Fund, such as updated investment strategies, portfolio managers, and asset allocation policies. The filing also modifies sections on risk factors, hedging transactions, and mortgage-related securities, while removing prior disclosures about the AllianceBernstein Mid Cap Growth Fund's risks.
2006-12-13 · 0000771726-06-000581
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current filing supplements variable annuity prospectuses for AXA Equitable Life Insurance Company, introducing the EQUI-VEST(R) At Retirement(SM) contract. It details an exchange offer for existing EQUI-VEST(R) contract holders, allowing eligible participants to exchange their contracts for the new deferred variable annuity with living benefits and enhanced death benefits. The new contract features no withdrawal charges and specific eligibility criteria, including age requirements, minimum account values, and restrictions on recent rollover contributions.
2006-12-06 · 0000771726-06-000569
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current filing is a prospectus for Equitable Financial Life Insurance Co's EQUI-VEST(R) At Retirement(SM) annuity contract, a deferred variable and fixed annuity offering retirement savings accumulation and income options. It outlines investment choices, contract types (IRA, NQ, TSA), and requirements for transferring existing contracts, with specific state availability details and risk disclosures.
2006-12-05 · 0000771726-06-000564
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current 424B3 filing updates the prospectus for Equitable Financial Life Insurance Co.'s retirement programs, specifically addressing changes to withdrawal charge waivers in Massachusetts. It clarifies that contracts issued on or after November 27, 2006, no longer qualify for withdrawal charge waivers under conditions of disability, terminal illness, or nursing home confinement. This supplement modifies state-specific terms for SEP, SARSEP, SIMPLE IRA, and Vantage contracts in Massachusetts, contrasting with previous filings for Utah that included different withdrawal charge structures.
2006-11-30 · 0000771726-06-000562
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current filing updates the prospectus for AXA Equitable's EQUI-VEST retirement programs, specifically addressing withdrawal charge adjustments for Utah-based contracts. It modifies the state table to reflect revised withdrawal charge structures for SIMPLE IRA Series 400 and Series 800 contracts issued after November 27, 2006. The changes detail percentages applied to contributions based on investment duration, with reduced charges for later contract years.
2006-11-21 · 0000771726-06-000558
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
Use of proceeds No issuer proceeds; related to portfolio substitution
Equitable Financial Life Insurance Co. issued a notice regarding the substitution of the Laudus Rosenberg VIT Value Long/Short Equity Portfolio with a newly created EQ/AXA Rosenberg Value Long/Short Equity Portfolio under AXA Equitable variable annuities. The substitution, effective November 17, 2006, transferred assets without impacting investment allocations or account values. Corrected expense information for the surviving portfolio was provided, with no material changes to fees or investment strategies.
2006-11-16 · 0000771726-06-000554
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The filing announces the substitution of the Laudus Rosenberg VIT Value Long/Short Equity Portfolio with a new EQ/AXA Rosenberg Value Long/Short Equity Portfolio under AXA Equitable variable annuities. The transfer, effective November 17, 2006, involves asset reallocation without impacting investment allocations or account values. Corrected expense information is provided, and temporary fee waivers for transfers out of the surviving option are noted.
2006-11-16 · 0000771726-06-000549
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current 424B3 filing for AXA Equitable Life Insurance Company updates state-specific provisions in the prospectus for Washington residents, modifying features like guaranteed interest options, investment simplifiers, and benefit availability. It also clarifies administrative charges, withdrawal policies, and disability benefits. This supplement follows a prior filing from August 2006, which addressed fund substitutions and fee adjustments.
2006-11-14 · 0000771726-06-000543
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
Use of proceeds Fund substitution and expense restatement
This supplement updates the prospectuses for various AXA Equitable Life Insurance Company products, focusing on the replacement of the Laudus Rosenberg VIT Value Long/Short Equity portfolio with the EQ/AXA Rosenberg Value Long/Short Equity Portfolio by December 1, 2006, pending regulatory approval. It restates portfolio expenses and removes expense example information for the surviving option.
2006-08-31 · 0000771726-06-000493
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current filing updates prospectus information for AXA Equitable Life Insurance Company, focusing on replacing the Laudus Rosenberg VIT Value Long/Short Equity portfolio with the EQ/AXA Rosenberg Value Long/Short Equity Portfolio by December 1, 2006, subject to regulatory approval. It revises fee tables and removes outdated expense examples for the new portfolio, while retaining other prospectus details unchanged.
2006-08-30 · 0000771726-06-000477
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current filing is a supplement to the prospectus for AXA Equitable Retirement Income for Livesm contracts, effective September 18, 2006. It modifies the section on how withdrawals affect the guaranteed minimum death benefit, replacing the previous wording with a new calculation method. This follows a prior supplement from August 25, 2006, which addressed portfolio name changes.
2006-08-30 · 0000771726-06-000466
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
This supplement updates the prospectus for the Members Retirement Program, reflecting changes to the names of certain variable investment options. The modifications include rebranding of fund names to align with new affiliations, with effective dates specified for each change. The document emphasizes that other prospectus information remains unchanged.
2006-08-23 · 0000771726-06-000430
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
This supplement updates the prospectus for Equitable Financial Life Insurance Co.'s retirement investment products, detailing changes to portfolio names and fee structures. It reflects modifications to variable investment options, including effective dates for name changes and updated expense disclosures.
2006-08-23 · 0000771726-06-000429
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
This supplement updates the prospectus for Equitable Financial Life Insurance Co.'s Retirement Investment Account (RIA) by modifying portfolio names, adjusting fees for the EQ/Small Cap Value portfolio, and announcing changes to investment advisers. Key updates include effective date changes for fund name revisions, a new fee structure for EQ/Small Cap Value, and appointments of Franklin Advisers, Inc. and BlackRock as advisers, subject to regulatory approval.
2006-08-23 · 0000771726-06-000427
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current 424B3 filing supplements the May 1, 2006 prospectus for Equitable Financial Life Insurance Co.'s Retirement Investment Account (RIA) contract. Key updates include portfolio name changes, fee table adjustments for EQ/Small Cap Value, and investment adviser transitions. Franklin Advisers, Inc. becomes an adviser to EQ/Small Cap Value, while BlackRock replaces Mercury Advisors as a sub-adviser. The filing also clarifies expense limitations and reimbursement terms under ongoing agreements with AXA Equitable.
2006-08-23 · 0000771726-06-000426
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
This supplement updates the prospectus for Equitable Financial Life Insurance Co's variable annuity products, adding new variable investment options under EQ Advisors Trust, revising fee tables, and disclosing portfolio name changes. It outlines updated expense structures, including management fees, 12b-1 fees, and expense limitations, while noting regulatory approvals required for new offerings.
2006-08-22 · 0000771726-06-000412
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current filing supplements the prospectus for Equitable Financial Life Insurance Co's variable annuity products, introducing new variable investment options under AXA Premier VIP Trust and EQ Advisors Trust, effective September 18, 2006. It includes updated fee tables, portfolio name changes, and revised examples of investment costs. The previous filing focused on replacing the underlying mutual fund for the Equity Income Fund with Dodge & Cox Stock Fund.
2006-08-21 · 0000771726-06-000387
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
This supplement updates the prospectus and statement of additional information for the American Dental Association Members Retirement Program, effective September 15, 2006. It details changes to the Equity Income Fund option, including the replacement of the underlying mutual fund from Putnam Equity Income Fund to Dodge & Cox Stock Fund and adjustments to fee structures. Other modifications include updates to fee tables, examples, and redemption charge disclosures.
2006-08-03 · 0000771726-06-000358
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current 424B3 filing updates the prospectus and statement of additional information (SAI) for the American Dental Association Members Retirement Program, effective September 15, 2006. Key changes include replacing the Equity Income Fund's underlying mutual fund from Putnam Equity Income Fund to Dodge & Cox Stock Fund, updating fee structures, and revising examples. The previous filing focused on Modified Contracts for the School District of Philadelphia's 403(b) Plan, with distinct modifications related to administrative and withdrawal charges.
2006-08-03 · 0000771726-06-000357
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current 424B3 filing supplements the prospectus for AXA Equitable's Equi-Vest employer-sponsored retirement programs, specifically modifying the terms of Modified Contracts for the School District of Philadelphia's 403(b) Plan. Key changes include the waiver of the annual administrative charge and revised withdrawal charge provisions, expanding exceptions for hardship withdrawals, disability, and other specific circumstances.
2006-07-19 · 0000771726-06-000354
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The supplement updates state-specific provisions and contract features for AXA Equitable's Accumulator variable annuity contracts. Key changes include modifications to free-look periods in California, annuitization rules in Florida, restrictions on Charitable Remainder Trusts, and temporary liberalization of guaranteed interest option allocations. State-specific variations in benefits and investment options are detailed, with updates to New York and Oregon provisions.
2006-07-10 · 0000771726-06-000351
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current filing is a prospectus for AXA Equitable's Accumulator(R) deferred annuity, offering variable and fixed investment options, retirement savings accumulation, and income benefits. It details contract types (e.g., IRAs, QP, TSA), investment portfolios, fees, and state-specific availability. The document emphasizes tax-deferred growth, death and income benefits, and risks associated with market performance.
2006-06-15 · 0000771726-06-000323
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
Class IB/B and Class II
The filing supplements the Prospectus for Equitable's Employer-Sponsored Retirement Programs, focusing on Modified Oregon TSA Contracts. Key updates include reduced separate account fees from 1.49% to 0.90%, inclusion of 12b-1 fees in specific share classes, and waivers of withdrawal and administrative charges. The document emphasizes fee structures and tax considerations for 403(b) plans in Oregon.
2006-05-31 · 0000771726-06-000306
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
Variable Annuity Contract
The current 424B3 filing for AXA Equitable Life Insurance Company's Accumulator Plus variable annuity updates provisions related to guaranteed principal benefit options, credit recovery, and death benefits. Key modifications include adjustments to how account values are reduced when contributions are made within one year of an annuitant's death, changes to credit application and recovery rules, and clarifications on guaranteed minimum death benefits. These updates aim to align with regulatory requirements and clarify terms for policyholders.
2006-03-06 · 0000771726-06-000090
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current 424B3 filing for AXA Equitable Life Insurance Company updates the prospectus for the Accumulator(R) Plus(SM) product, focusing on the extension of a temporary liberalization period for allocations to the Guaranteed Interest Option (GIO). The supplement clarifies that the 100% GIO allocation limit, previously extended to October 31, 2006, will revert to 25% after this date. It also emphasizes that existing GIO assets remain unaffected, while new contributions must comply with the 25% limit post-October 31, 2006. The filing does not include prior California-specific free look period details present in an earlier supplement.
2006-02-15 · 0000771726-06-000044
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current 424B3 filing updates prospectus information for AXA Equitable's Accumulator annuity products, focusing on California-specific modifications. It details enhanced free look period provisions for policyholders aged 60+ and outlines 'return of contribution' treatment options for variable annuities. The filing emphasizes procedural changes around contribution allocation, refund mechanisms, and reallocation timelines.
2006-02-10 · 0000771726-06-000040
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current 424B3 filing updates the prospectus for AXA Equitable Life Insurance Company's Accumulator(R) annuity products, primarily changing the address for handling contributions. The previous filing focused on tax-related modifications for TSA contracts, including designated Roth contributions and distribution rules. The current supplement emphasizes that other prospectus information remains unchanged.
2006-02-08 · 0000771726-06-000018
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current filing updates the variable annuity prospectuses for Equitable Financial Life Insurance Co., focusing on modifications to Tax-Sheltered Annuity (TSA) contracts. Key changes include allowing designated Roth contributions under Section 402A of the Code, limitations on rollovers from Roth IRAs, and updated rules for distributions and tax treatments of Roth accounts. The supplement also clarifies withdrawal restrictions and required minimum distributions for Roth contribution funds.
2006-01-13 · 0000771726-06-000006
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The filing updates prospectuses for variable annuity and life insurance products issued by AXA Equitable, MONY, and MONY America. It notes changes to investment managers for specific portfolios and updates regarding the distribution of contracts following AXA Financial's sale of Advest to Merrill Lynch.
2005-12-19 · 0000771726-05-000433
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current filing updates prospectuses for variable annuity and life insurance products issued by AXA Equitable, MONY, and MONY America. It notes changes in investment managers for specific portfolios, the sale of Advest to Merrill Lynch, and a state-specific adjustment for Massachusetts contracts.
2005-12-19 · 0000771726-05-000432
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The filing updates the prospectus for AXA Equitable's Accumulator contracts, introducing a benefit base reset option and 'no lapse guarantee' for certain guaranteed income and death benefits. These changes, effective November 1, 2005, apply to contracts with specific application dates. The supplement also adjusts state-specific provisions, notably removing a disability-related section for Massachusetts contracts.
2005-12-07 · 0000771726-05-000429
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current filing supplements the May 2005 prospectuses for AXA Equitable's Accumulator products, introducing two new features: a 'benefit base reset option' for guaranteed minimum income and death benefits effective November 1, 2005, and a 'no lapse guarantee' for contracts with application dates from January 2005. These updates modify sections of the prospectus related to contract features, charges, and beneficiary protections, with details on eligibility, waiting periods, and limitations.
2005-10-14 · 0000771726-05-000411
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
This 424B3 filing serves as a supplement to variable annuity prospectuses, introducing new variable investment options (EQ/Evergreen International Bond and EQ/Legg Mason Value Equity) and updating fee structures, examples, and portfolio names. It also notes the removal of the EQ/Ariel Appreciation II option and includes regulatory approval conditions for changes. The document emphasizes hypothetical cost examples and risks related to market value adjustments and regulatory approvals.
2005-09-20 · 0000771726-05-000400
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current filing is a supplement to the May 1, 2005 prospectus for Accumulator(R) Plus(SM) and Accumulator(R) Advisor(SM), announcing new variable investment options, fee adjustments, portfolio name changes, and a temporary extension of the Guaranteed Interest Option (GIO) allocation limit. It includes detailed fee tables, examples of investment costs, and updates to portfolio names under EQ Advisors Trust.
2005-08-19 · 0000771726-05-000354
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current filing supplements the variable annuity prospectuses for Equitable Financial Life Insurance Co., introducing three new variable investment options under EQ Advisors Trust, updating fee tables, providing expense examples, and announcing portfolio name changes effective October 17, 2005. It also modifies the distribution section to clarify fees and potential payments to distributors.
2005-08-19 · 0000771726-05-000348
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current filing updates the prospectus for AXA Equitable Life Insurance Company's Members Retirement Program and Retirement Investment Account(R), announcing planned name changes for two investment options. These changes, pending regulatory approval, will take effect on October 17, 2005, and involve rebranding 'EQ/Fi Small/Mid Cap Value' to 'EQ/Fi Mid Cap Value' and 'EQ/JP Morgan Value Opportunities' to 'EQ/JPMorgan Value Opportunities'. The supplement clarifies that other prospectus information remains unchanged.
2005-08-19 · 0000771726-05-000332
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
This supplement updates the prospectus for AXA Equitable Life Insurance Company's Members Retirement Program and Retirement Investment Account(R), effective August 31, 2005. It details planned name changes for two investment options, subject to regulatory approval, scheduled for October 17, 2005. The changes involve rebranding 'EQ/Fi Small/Mid Cap Value' to 'EQ/Fi Mid Cap Value' and 'EQ/JP Morgan Value Opportunities' to 'EQ/JPMorgan Value Opportunities' for specific contractholders.
2005-08-19 · 0000771726-05-000331
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
This 424B3 filing serves as a supplement to the prospectuses for AXA Equitable Life Insurance Company's Members Retirement Program and Retirement Investment Account, updating portfolio/option name references. The changes include rebranding 'EQ/Fi Small/Mid Cap Value' to 'EQ/Fi Mid Cap Value' and 'EQ/JP Morgan Value Opportunities' to 'EQ/JPMorgan Value Opportunities,' pending regulatory approval. The document emphasizes that other prospectus information remains unchanged.
2005-08-19 · 0000771726-05-000330
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current filing updates the prospectuses for AXA Equitable's retirement programs, announcing name changes for specific investment portfolios. It notes that references to 'EQ/Fi Small/Mid Cap Value' will be replaced with 'EQ/Fi Mid Cap Value' and 'EQ/JP Morgan Value Opportunities' with 'EQ/JPMorgan Value Opportunities,' effective October 17, 2005, pending regulatory approval. The document emphasizes that other information in the prospectus remains unchanged.
2005-08-19 · 0000771726-05-000329
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The filing updates prospectuses for AXA Equitable's variable life insurance and annuity products, focusing on changes to investment sub-advisers for two Trust portfolios. Effective June 13, 2005, Bridgeway Capital Management replaces Brown Capital Management as the sub-adviser for the EQ/Calvert Socially Responsible Portfolio, while The Dreyfus Corporation replaces Alliance Capital Management for the EQ/Money Market Portfolio. Calvert Asset Management continues its role in social research and screening for the Socially Responsible Portfolio.
2005-07-13 · 0000771726-05-000304
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The filing updates prospectuses for variable life insurance, variable annuity products, and the EQ Advisors Trust, focusing on changes to investment sub-advisers for specific portfolios. Effective June 13, 2005, Bridgeway Capital Management replaces Brown Capital Management as the adviser for the EQ/Calvert Socially Responsible Portfolio, while The Dreyfus Corporation replaces Alliance Capital Management for the EQ/Money Market Portfolio. The supplement also notes updates to portfolio descriptions, risk disclosures, and management details.
2005-07-13 · 0000771726-05-000303
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current filing updates prospectuses for variable life insurance, annuity products, and trust portfolios, reflecting changes in investment sub-advisers. Key updates include replacing Brown Capital Management with Bridgeway Capital Management for the EQ/Calvert Socially Responsible Portfolio, Alliance Capital Management with The Dreyfus Corporation for the EQ/Money Market Portfolio, and adding Legg Mason Capital Management and Post Advisory Group for new portfolios. These changes aim to adjust investment strategies and risk management approaches.
2005-06-17 · 0000771726-05-000275
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The filing updates prospectuses for variable life insurance, annuity products, and trust portfolios, announcing changes to investment sub-advisers for multiple portfolios. Key updates include Bridgeway Capital replacing Brown Capital for the EQ/Calvert Socially Responsible Portfolio, The Dreyfus Corporation replacing Alliance Capital for the EQ/Money Market Portfolio, Legg Mason replacing Provident for the AXA Premier VIP Aggressive Equity Portfolio, and Post Advisory Group replacing Alliance Capital for the AXA Premier VIP High Yield Portfolio. These changes took effect between June 13 and June 27, 2005.
2005-06-17 · 0000771726-05-000274
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The filing updates prospectuses for variable life insurance, annuity products, and trust portfolios, detailing changes in investment sub-advisers. Key changes include Bridgeway Capital Management replacing Brown Capital for the EQ/Calvert Socially Responsible Portfolio, The Dreyfus Corporation replacing Alliance Capital for the EQ/Money Market Portfolio, Legg Mason Capital Management replacing Provident for the AXA Premier VIP Aggressive Equity Portfolio, and Post Advisory Group replacing Alliance Capital for the AXA Premier VIP High Yield Portfolio. These updates reflect shifts in portfolio management strategies and risk profiles.
2005-06-17 · 0000771726-05-000273
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current filing updates prospectuses for variable life insurance, annuity products, and trust portfolios, highlighting changes in investment sub-advisers. Key updates include replacing advisers for the EQ/Calvert Socially Responsible Portfolio, EQ/Money Market Portfolio, AXA Premier VIP Aggressive Equity Portfolio, and AXA Premier VIP High Yield Portfolio, effective between June 13 and June 27, 2005. The supplement also revises risk disclosures and portfolio management details.
2005-06-17 · 0000771726-05-000261
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The filing updates prospectuses for variable life insurance, annuity products, and the EQ Advisors Trust, reflecting changes in investment sub-advisers for two portfolios. Effective June 13, 2005, Bridgeway Capital Management replaces Brown Capital Management as the sub-adviser for the EQ/Calvert Socially Responsible Portfolio, while The Dreyfus Corporation replaces Alliance Capital Management for the EQ/Money Market Portfolio. The supplement details investment strategies, risk management practices, and updated disclosures for these portfolios.
2005-06-17 · 0000771726-05-000256
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
The current 424B3 filing updates prospectuses for AXA Equitable's variable life insurance, variable annuity products, and EQ Advisors Trust. It details changes to investment sub-advisers for two Trust portfolios: Bridgeway Capital Management replacing Brown Capital Management for the EQ/Calvert Socially Responsible Portfolio, and The Dreyfus Corporation replacing Alliance Capital Management for the EQ/Money Market Portfolio. Updates include revised investment strategies, risk disclosures, and portfolio management details.
2005-06-17 · 0000771726-05-000254
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
This supplement modifies the prospectus for AXA Equitable's Equi-Vest employer-sponsored retirement programs, specifically for the School District of Philadelphia. Key changes include waiving the annual administrative charge and adjusting withdrawal charge conditions to allow exceptions for specific circumstances like disability, hardship, or death. The document emphasizes that other prospectus information remains unchanged.
2005-06-01 · 0000771726-05-000242
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
Use of proceeds For retirement savings through investment options
The filing serves as a prospectus for the American Dental Association Members Retirement Program, a deferred group annuity contract issued by AXA Equitable Life Insurance Company. It outlines investment options for retirement savings, including guaranteed rate accounts, equity funds, and bond funds, with details on fees, risks, and participant services. The document emphasizes that securities are not insured by the FDIC and are subject to investment risks.
2005-05-05 · 0000771726-05-000234
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
First tracked pre-IPO filing for this issuer.
unit · Use of proceeds to provide retirement savings options for participants · Flags units
The document is a prospectus for the American Dental Association Members Retirement Program, a deferred group annuity contract issued by AXA Equitable Life Insurance Company. It outlines investment options for tax-deferred retirement savings, including guaranteed rate accounts, money market guarantees, and various equity and bond funds. The program allows participants to allocate contributions across thirteen investment options, with details on fees, risks, and administrative procedures.
2005-05-05 · 0000771726-05-000233
Comparable Deals
1 comparable deal
FinancialsLast 18 months
Only 0 strict matches; expanded to 1 using nearest neighbors.
Recent News
No recent news stored for this issuer.